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Tissue engineering has emerged as a promising alternative to traditional surgical 
procedures in regenerating or repairing damaged organs. One of the major strategies of 
tissue engineering is to culture isolated cells on a three-dimensional scaffold, which 
will be developed into a functional tissue with proper stimulation. In this study, a novel 
scaffolding system via polymer microspheres was developed for the purpose of 
constructing an engineered liver tissue to solve the shortage of liver donors. 
Poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV, 8% PHV), a type of 
microbial polyester, was chosen as the scaffold material due to its biodegradability and 
biocompatibility. PHBV microspheres with the sizes between 100-300µm were found 
to be ideal in supporting liver cells growth. Optical and scanning electron microscope 
images showed that the microspheres were assembled by the cells to form tissue-like 
constructs after two weeks of culture, while confocal images confirmed that more than 
90% of cells were alive. Compared to the cells cultured on positive control, HepG2 
cells grown on microsphere scaffold showed a proliferation up to 1.9 times more than 
that of positive control. HepG2 cells grown on microsphere scaffold secreted albumin 
2-4 times more than that on the positive control, which indicated an improved hepatic 
function. 
Three types of extracellular matrix (ECM) proteins, namely collagen, fibronectin 
and laminin were covalently conjugated onto the surfaces of PHBV microspheres to 
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improve the biocompatibility of the scaffold. The improved proliferation of cells 
cultured on mixed protein-conjugated samples, which was around 1.4 times greater 
than single protein conjugated samples (collagen), suggested that the proliferation of 
Hep3B cells did not just depend on single protein, but rather, involved complex 
interactions with all of the ECM components. Furthermore, it was found that 
hepatocytes with round morphology performed better hepatic functions while having 
lower proliferation. Thus, during the design of a tissue engineering system, a scaffold 
showing different surface properties at different cell development stages might be 
necessary. 
One promising feature of microsphere scaffolds is that the growth factors can be 
encapsulated into the scaffold directly. Three types of polymer microspheres (PHBV, 
Poly(lactic-co-glycolic acid) PLGA, and PHBV/PLGA) with distinct release profiles 
of hepatocyte growth factor (HGF) were fabricated. Sustained delivery of HGF from 
PHBV/PLGA composite microsphere with a core-shell structure was achieved while 
maintaining bioactivity for at least 40 days. The high encapsulation efficiency 
(88.62%), moderate degradation rate and well preserved structure after three months of 
incubation indicated that the composite microspheres would therefore be more suitable 
as a scaffold. It was also found that bovine serum albumin (BSA) was a suitable model 
protein for HGF and functioned as stabilizer to prevent the denaturation of HGF during 
the fabrication process. These were justified by the similar release profiles of BSA and 
HGF as well as the well-maintained bioactivity of HGF.  
Vascularization of the scaffolding system is a prerequisite for the success in 
engineering large tissues such as the liver. Human umbilical vein endothelial cells 
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were cultured on gelatin microspheres for the application of in vitro vascularization. 
Basic fibroblast growth factor (bFGF) was then incorporated into the gelatin 
microspheres based on ionic complexation. Compared to blank microspheres, the 
proliferation of cells grown on bFGF loaded gelatin microspheres was improved up to 
1.3 times, which indicated that the bioactivity of bFGF was well maintained during the 
incorporation and release process. Capillary-like structure was formed after the 
incorporation of endothelial cells coated gelatin microspheres into a fibrin gel matrix, 
and which could be used to prevascularize the engineered liver tissue. 
In summary, the viability of using a novel microsphere scaffolding system to 
regenerate liver tissue was explored in this study. The microsphere scaffold can be 
easily assembled into various shapes suitable for surgical implantation. It also offers 
controllable surface modification, growth factor encapsulation properties as well as in 
vitro vascularization, which show great promise for the production of a complete liver 
tissue engineering system. 
 
Keywords: tissue engineering, scaffold, polymeric microsphere, surface modification, 
growth factor, liver regeneration  
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1.1 Background and Motivations 
Every year millions of people in the world suffer from tissue damage or end-stage 
organ failure. The traditional procedures to treat these patients include organ 
transplantation, performing surgical reconstruction and using mechanical devices such 
as kidney dialyzers. Although there have been tremendous advances in these therapies 
and countless lives have been saved, the declining availability of compatible donor 
organs as well as high cost of treatment severely limit their applications. For example, 
in the United States, about 30,000 people are on the waiting list for liver 
transplantation each year while only ten percent of them can get a donor liver, and in 
Singapore alone, around 15 patients die each year while waiting for a liver.  
The science of tissue engineering, which aims to develop biological substitutes to 
maintain or regenerate damaged organs, has therefore emerged from the challenges 
posed by these limitations, and has turned out to be a promising alternative to 
regenerate failed organs. One of the major strategies of tissue engineering is to culture 
isolated cells, either from the patients (autologous) or other sources (allogenous or 
xenogenous), on a three-dimensional (3D) scaffold. Under proper environment and 
stimulation, a functional engineered tissue will be developed which should be 
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structurally and functionally integrated into the body upon being grafted into the 
patient. Important considerations concerning the success of tissue engineering include 
the biology and spatial organization of the organ to be replaced, the cell source, in vitro 
culture techniques, and the design of the scaffold. Among these numerous factors, 3D 
scaffolds play a vital role, which provide temporary templates for cells to attach, 
proliferate and produce extracellular matrix (ECM) proteins, and also to encourage the 
migration of cells from the surrounding healthy tissue into the scaffold. Scaffolds may 
also provide a spectrum of bioactive molecules, such as ligands, growth factors, 
hormones and enzymes to regulate the behaviors of the cells. 
 Finding appropriate scaffold for a specific organ has always been a significant 
challenge for tissue engineers. Two-dimensional (2D) polymer films or meshes 
scaffolds are the simplest forms, and to date, the most successful clinical case is to 
engineer skin tissues with polymer mesh. However, to some extent, the polymer films 
or meshes are only suitable for organs with simple structures, while many types of 
cells would dedifferentiate quickly when being cultured in the 2D environment. 
Applications of polymer rods, hydrogel and sponges for bone tissue repair and 
cartilage regeneration have been also extensively investigated. In these cases, the 
scaffolds are usually fabricated to be similar in shape as the defects for easy 
implantations. However, for more complex organs, such as the liver, the research is 
still in its infancy. One big problem is that the quick dedifferentiation of primary 
hepatocytes (liver cells) to lose the normal liver functions (albumin secretion, 
detoxification ability) when cultured in vitro without the appropriate environment. The 
lack of sufficient oxygen and nutrient supply may also induce the death of the cells. 
Therefore, a novel scaffolding system which could provide the proper environment to 
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preserve the phenotype of the liver cells as well as enough nutrients is necessary for 
the success of engineering a liver tissue, forming the main motivation for this project.  
Microspheres have been traditionally used as drug delivery vehicles or carriers to 
harvest cells. The unique 3D environment offered by microspheres can improve cell 
proliferation as well as preserve their differentiated functions. Based on these 
advantages, we propose to use microspheres as scaffold to regenerate liver tissue. 
Unlike traditional scaffolds with specific shape or structure, in a microsphere 
scaffolding system, cells could be first seeded on individual microsphere, and the 
microspheres could then be assembled into various shapes suitable for different tissue 
or defects. Microspheres also offer easy and controllable surface modification to 
enhance cell-scaffold interactions. Furthermore, growth factors and other molecules 
can be encapsulated into the scaffold to regulate the cell behavior as they are released 
in a controlled manner. Thus, microsphere scaffolds offer clear cut benefits. However, 
studies on using microspheres as scaffolds are still limited especially for liver tissue 
engineering. Therefore, the major incentive of this project is to broaden the application 
of microspheres as tissue engineering scaffold and design a system with suitable 
dimension, structure as well as biocompatible surface properties, and controllable 
delivery of growth factors for the application in liver tissue regeneration.  
Besides the structure of the scaffold, the materials are equally important. The 
scaffold materials should be bio-absorbed over time and the spaces occupied by the 
scaffolds should be replaced by secreted ECM or regenerated tissue. Biodegradable 
polymers are the most widely used material which includes natural polymers such as 
collagen and laminin, and synthetic polymers such as poly(lactic-co-glycolic acid) 
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(PLGA). The advantage of natural polymers is their good biocompatibility. However, 
poor control of the mechanical properties, molecular weight and biodegradability in 
addition to limited supply and high cost are some of their disadvantages. On the other 
hand, synthetic polymers are becoming more and more popular for use in tissue 
engineering due to their ease in controlling their chemical and physical properties, 
degradation rate and relatively low cost. Poly (3-hydroxybutyrate) (PHB) and poly (3-
hydroxybutyrate-co-3-hydroxyvalerate) (PHBV), which are polyesters produced by 
bacteria, have many similar properties to PLGA and have also received much attention 
in applications for drug delivery and surgical operation. Moreover, as they are 
bacterially synthesized polyesters, PHB and PHBV could be more biocompatible than 
the synthesized polyesters and possess controllable mechanical strength which the 
natural polymers do not have. However, PHBV has been less widely studied for tissue 
engineering and further studies need to be carried out to verify its viability in this field.  
1.2 Hypothesis 
It is hypothesized that three-dimensional PHBV microspheres are suitable 
substrates to guide liver cell growth and to regenerate the liver. Surface modification 
of the microsphere with ECM proteins can improve the biocompatibility of the 
scaffold and therefore promote cell adhesion, proliferation and differentiation. 
Encapsulation of growth factors in the microsphere will further simulate the in vivo 
microenvironment to regulate liver cell behavior and enable the cell-scaffold construct 
function properly. The overall goal of this research is to design a microsphere 
scaffolding system and to construct an engineered liver tissue with this system to 
reduce the cost of implantation and to solve the shortage of donated liver.  
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1.3 Objectives 
This project seeks to explore the viability of using polymer microspheres as 
scaffold to engineer liver tissue. The objectives in this thesis include: 
Objective 1. To fabricate PHBV microsphere scaffolds and to determine the 
optimum dimension to guide the growth of liver cells. The microspheres were 
fabricated by using the emulsion solvent evaporation technique. The morphology and 
size distributions of the microspheres were characterized by scanning electron 
microscopy (SEM) and particle size analyzer. Human hepatoma cell lines, Hep3B and 
HepG2 were cultured on the microspheres with different sizes to determine the 
optimum dimension of microspheres for the growth of liver cells.  
Objective 2. To modify the surfaces of the microspheres with bioactive 
molecules to improve their biocompatibility. The microspheres were conjugated 
with three types of ECM proteins, collagen, laminin and fibronectin, and the surface 
densities of proteins and atomic composition were characterized by using Micro 
BCATM protein assay and X-ray photoelectron spectroscopy (XPS) respectively. 
Hep3B cells were cultured either on microsphere conjugated with single protein type 
or a mixtures of microspheres individually conjugated with three types of proteins 
respectively, to study the interactions between various proteins and cells to regulate 
cell activity and functionality.  
Objective 3. To encapsulate growth factors in the microsphere scaffold to 
regulate the cell behaviors. PHBV and PLGA were chose as the microsphere scaffold 
materials for the encapsulation of bovine serum albumin (BSA) and hepatocyte growth 
factor (HGF). The release of BSA served as the model for HGF since both proteins 
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have similar molecular weights and hydrophilicity, and the co-encapsulation of BSA 
with HGF were believed to be able to preserve the bioactivity of the growth factor by 
reducing its exposure to organic solvents. The effects of polymers on the morphologies, 
release and degradation profiles of the microsphere scaffolds were studied and the 
bioactivity of released HGF was assessed by using Hep3B cells and primary 
hepatocytes. 
Objective 4. To culture endothelial cells on gelatin microspheres for a 
preliminary study of in vitro angiogenesis. Gelatin microspheres were fabricated 
using a water-in-oil emulsion technique and cross-linked with glutaraldehyde (GTA). 
Basic fibroblast growth factors (bFGF), which can improve angiogenesis in vivo, were 
incorporated into the gelatin microspheres by electrostatic interactions. The gelatin 
microspheres pre-seeded with human umbilical vein endothelial cells (HUVECs) were 
embedded into a fibrin gel to stimulate the formation of capillary-like structure in vitro.  
This study involves the design of a novel tissue engineering system with polymer 
microsphere as scaffold, which could be applied to regenerate liver tissue and other 
similar soft tissues, like the kidney and the heart, to solve the shortage of organ donors. 
Furthermore, the results of surface modification will improve our understanding on the 
synergistic effects of ECM proteins on cells, and the growth factor delivery system can 
be developed as a feasible way in the application of soluble growth factors for tissue 
engineering. The preliminary study on in vitro angiogenesis could be used to pre-
vascularize the scaffold for the purpose of providing oxygen, blood and nutrient to the 
cells growing in the deeper sections the scaffold.  
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Although the final purpose of this study is to regenerate a defective liver tissue, no 
in vivo animal experiments will be included in this thesis. All tests are based on in 
vitro cell culture experiments. Since the objectives of this thesis are to prove the 
viability of microsphere as scaffold for liver tissue engineering and to study the 
response of the liver cell in this microsphere scaffold system, in vitro cell culture is 
adequate for this purpose in addition to having some advantages, for example, relative 
easier to characterize and analyze, repeatable and low cost. Therefore, in vivo 
implantation is out of the scope of this thesis and can be considered as the future work. 
In the next chapter, a literature review on liver tissue engineering will first be 
given, followed by discussions on the biomaterials and scaffolds for tissue engineering. 
Surface modification of scaffold, the application of drug delivery technique for tissue 
engineering and in vitro angiogenesis process will be also reviewed in detail. All these 
literature review will provide the theoretical basis for this study. 
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2.1 Tissue Engineering 
Organ transplantation, surgical reconstruction and the use of mechanical devices 
are the main medical procedures used currently to treat patients with tissue damage or 
organ loss. Although these procedures have saved countless lives, they are imperfect 
with inherent limitations. Liver and kidney are among the commonly transplanted 
organs today. The successful application of organ transplantation is limited not by the 
surgical technique but by the declining availability of compatible donor organs, as well 
as high cost. Furthermore, long-term and massive drug administration is often required 
to maintain the normal function of the transplanted organ and to protect it from 
immune rejection. Surgical reconstruction often involves grafting tissues from one part 
of the patient to another part (autograft) which may result in donor site morbidity. 
Mechanical devices such as kidney dialysers are still not good enough to perform 
integrated functions of whole organs. Most of them can only serve as a temporary 
treatment to sustain the patient until a donated organ is available. Other devices, such 
as artificial heart valves, which are integrated into the patients for long-term 
applications, are subjected to mechanical failure (Langer and Vacanti, 1993; Hubbell 
and Langer, 1995). 
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The limitations of the current therapies encourage researchers to find alternatives, 
such as regeneration of failed organs. The science of tissue engineering, which 
combines the disciplines of engineering and life science to create functional tissue 
substitutes for the failed organs, therefore emerged from the challenges and advances a 
promising way to improve the health of human beings. The term “Tissue Engineering” 
was initially coined by National Science Foundation (NSF) in 1987 and defined as “the 
application of the principles and methods of engineering and life sciences toward the 
fundamental understanding of structure-function relationships in normal and 
pathological mammalian tissues, and the development of biological substitutes to 
restore tissues” (∗).  
In tissue engineering, three general strategies are commonly used to create a 
functional tissue: (1) use of isolated cells or cell substitutes; (2) use of tissue-inducing 
substances; and (3) use of cells cultured on or within polymer matrices (Langer and 
Vacanti, 1993). All of these methods have shown some promising results, but only the 
third approach holds the promise of generating new tissue or organ in vitro and has 
thus become the major strategy for tissue engineering. Figure 2-1 is a typical schematic 
diagram for this strategy (Marler et al., 1998). Cells isolated from the patients 
(autologous) are seeded on or into three-dimensional (3D) scaffolds fabricated from 
natural or synthetic polymers. The cell-scaffolds are then cultured in static or dynamic 
environments to promote cellular remodeling and tissue formation. A functional 
engineered tissue will be thus developed, which would be structurally and functionally 
integrated into the body upon being grafted back to the patients. As the cells grow, 
they will secrete their own extracellular matrix (ECM). The scaffold should therefore 
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be biocompatible and biodegradable at a suitable rate so that the space occupied by the 
scaffold initially is eventually replaced by the regenerated natural tissue.  
 
Meeting the challenges of engineering tissue substitute means answering the 
question of how to imitate nature accurately. To do so, researchers should address at 
least three issues: (1) cell-related considerations such as cell source (autologous, 
allogeneic, xenogeneic and stem cell), and manipulation of cell proliferation and 
functions; (2) designing a 3D substrate which allows the cells to organize and remodel 
to develop into tissue-like constructs; and (3) integration of the tissue-like constructs 
into the living system (Nerem, 2000). Therefore, scientists from various fields 
Figure 2-1. Schematic representation of the tissue engineering approach 
(Adapted from Marler et al., 1998).  
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including biologists, material (especially polymer) experts, biomedical specialists and 
surgeons need to work together to meet the challenge and make tissue engineering a 
successful therapy for regenerating defective tissues.  
Investigators have attempted to engineer virtually every mammalian tissue 
including nerve, cornea, skin, cartilage, bone, tendon, muscles, liver, pancreas, and 
heart valves (Langer and Vacanti, 1993). To date, engineered skin tissue is the most 
successful in clinical application, and the efforts on engineering bone and cartilage 
tissues also show promising results. However, research on complex organs engineering, 
such as the liver, is still in its infancy and will be the object of discussion for this 
project. 
2.2 Liver and Liver Tissue Engineering 
2.2.1 Liver  
The reddish brown, wedge-shaped liver is one of the most sophisticated and 
complicated organs in the human body (Figure 2-2) (∗). The liver performs a variety of 
metabolic and synthetic functions which are crucial for life. It secretes bile for 
digestion and synthesizes plasma proteins (albumin, globulin etc.), which are essential 
components of blood. Another important function of the liver is to detoxify xenobiotic 
and endogenous toxins. The liver also functions as a center of storage for glycogen and 
vitamins A, B, D and K (∗). The liver consists of multiple types of cells, such as 
hepatocytes, sinusoidal endothelial cells, stellate cells, and kupffer cells (Gumucio et 
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al., 1996). Among them, hepatocytes make up more than 70% of the liver and perform 
most of the liver-specific functions mentioned above.  
 
Acute and chronic hepatitis, cirrhosis and liver cancer kill thousands of people 
every year. Currently, the main surgical treatment of severe end-stage liver disease is 
liver transplantation. However, the declining availability of donor livers and high 
medical cost led to patients losing their lives while waiting for liver donation. This 
situation is getting worse every year (Langer and Vacanti, 1993). Alternative therapies 
are urgently needed to overcome the shortage, and tissue-engineered liver is one 
candidate.   
2.2.2 Liver tissue engineering 
The research on liver tissue engineering can be traced back to more than 20 years 
ago when the use of injected hepatocytes to replace hepatic functions was investigated 
(Davis and Vacanti, 1996). In this strategy, isolated hepatocytes were injected into the 
Figure 2-2. Liver structure in human body. The highly vascularized 
system is essential for liver to perform normal function ∗. 
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defects directly with the hope that they can perform and restore the normal hepatic 
functions. However, necrosis and granuloma formation were frequently observed and 
it was difficult to distinguish injected hepatocytes from the host’s. As an improvement, 
hepatocytes were attached onto micro-carriers or encapsulated into biocompatible 
membranes before the injection. The micro-carrier/membrane allowed incorporation of 
ECM proteins into the substrate to prolong the survival of the cells and to stimulate 
cell organization. However these are only effective in providing short-term 
replacement of the hepatic functions. Development of implantable engineered live 
tissue for long-term hepatic support still requires much work.  
The various physiological functions and metabolic activities of the liver pose 
significant challenges to the engineering of implantable engineered liver tissue. 
Important considerations include the biology and spatial organization of the liver, the 
cell source, in vitro culture techniques, and the design of the scaffold. To date, 
culturing hepatocytes on biodegradable polymer scaffolds under proper 
microenvironment is believed to be a promising method to develop an implantable 
liver tissue (Davis and Vacanti, 1996). The scaffold acts as substrate to guide cell 
proliferation and functionality as well as to promote recomposition of the ECM. 
Furthermore, the scaffold can be modified to incorporate ligands for cell receptors and 
release soluble stimuli such as growth factors, to regulate cell proliferation and 
differentiation (Jagur-Grodzinski, 2006). The scaffold is so important for the success 
of tissue engineering that finding an appropriate scaffold for specific tissue 
regeneration has always been one of the primary tasks for tissue engineers. Therefore, 
a detailed literature review on the biocompatible scaffold and the biomaterials used to 
fabricate the scaffold is given in next section.  
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2.3 Biocompatible Scaffold and Biomaterials 
2.3.1 Biocompatible scaffold 
As a temporary replacement of the ECM, the polymer scaffold plays an essential 
role in tissue engineering. It guides the growth of seeded cells in vitro as well as 
encourages migration of cells from surrounding healthy tissue into the scaffolds after 
implantation. The scaffold must therefore satisfy the following requirements: (1) 
suitable structure and shape, (2) large surface to volume ratio and porosity, (3) 
appropriate mechanical and surface properties, and (4) biodegradability (Freed and 
Vunjak-Novakovic, 1998; Thomson et al., 2000). A large surface area is preferred so 
that a high number of cells can seed on/in the scaffold. A highly porous structure with 
interconnected pores can enhance cell migration and ingrowth from the local tissues. It 
can also promote the formation of vasculature into the scaffold to allow the exchange 
of oxygen, nutrients and removal of metabolic wastes. This is essential in engineering 
thick tissue since diffusion is not enough to provide oxygen and nutrients to the cells 
growth inside the scaffold. Mechanical properties of the scaffold are often critical for 
hard tissue (such as cartilage and bone) regeneration. The roughness, wettability and 
charge of the scaffold surface are also reported to affect cell attachment, proliferation 
and functionality. Last but not least, the scaffold should ideally be biodegradable over 
time allowing ECM proteins or regenerated tissue to replace the space it occupied 
initially. 
Various types of scaffolds have been studied for tissue engineering purpose in the 
last decade. Two-dimensional (2D) scaffolds such as polymer films or meshes made 
from nano-fibers are the simplest forms commonly used in preliminary experiments to 
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test the biocompatibility of the scaffold materials (Carlisle et al., 2000; Khang et al., 
2002; Kim et al., 2003; Majima et al., 2005). To date, the best clinical success is with 
engineered skin tissues using polymer mesh. However, to some extent, the polymer 
films or meshes are only suitable for organs with simple structures and organization. 
Moreover, many types of cells would dedifferentiate quickly when cultured in a 2D 
environment. 3D substrates are necessary to promote cell proliferation as well as to 
preserve the phenotype. Applications of polymer rods, hydrogel and sponges for bone 
tissue repair and cartilage regeneration have therefore been extensively investigated 
(Köse et al., 2003; Lin and Yen, 2004; Stevens et al., 2004; Wayne et al., 2005). 
Stevens et al developed a rapid-curing alginate gel system which was capable of 
supporting the growth of chondrocytes. When whole-tissue explants of periosteum 
were cultured in the gel for six weeks, significant expansion of periosteal explants 
were observed, which could be transplanted for the treatment of partial or full-
thickness defects in articular cartilage (Stevens et al., 2004). Lin et al fabricated 
alginate/hydroxyapatite (HAP) sponge for bone tissue engineering. The improved 
mechanical and cell-attachment properties suggested a promising approach to engineer 
bone tissue (Lin and Yen, 2004).  
 In these cases, for easy implantations, the scaffolds are usually fabricated to match 
only the architectures, structures and mechanical properties of defect sites. However, 
for more complex and highly vascularized organs such as the liver, this is insufficient. 
Besides the irregular shapes of the defects which limit the use of conventional 
scaffolds, another challenge is the quick dedifferentiation of primary hepatocytes 
leading to loss of the normal liver functions (such as albumin secretion, detoxification 
ability and etc). This occurs when the hepatocytes are cultured on polymer substrates 
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without an appropriate stimulation (Davis and Vacanti, 1996). Furthermore, when 
engineering thick tissue equivalents, diffusion alone would not be sufficient to provide 
oxygen and nutrients to cells growing in the deeper sections of the scaffolds (Griffith 
et al., 2005). Therefore, a novel scaffolding system which could preserve the 
phenotype of primary hepatocytes as well as allow enough nutrient exchange, in 
addition to being able to match the defect site physically, is necessary for the success 
of engineering a liver tissue.  
2.3.2 Microsphere scaffold 
Microspheres have been traditionally used as drug delivery vehicles or carriers to 
harvest cells (Jacobson and Ryan, 1982; Cao and Shoichet, 1999; Malda et al, 2003). 
The unique 3D environment offered by microspheres can improve cells’ proliferation 
and preserve their differentiated functions. However, using microspheres as a scaffold 
for tissue engineering is a new idea reported so far in only a few studies (Barrias et al., 
2005; Mercier et al., 2005;  Sahoo et al., 2005). Mercier et al. (2005) demonstrated the 
successful application of poly(lactide-co-glycolide) (PLG) microspheres as a moldable 
scaffold for cartilage repair. They reported that the cartilagenous tissue formed 
maintained thickness, shape, and chondrocyte collagen type II phenotype. According 
to Barrias, calcium titanium phosphate (CTP) microspheres improved bone marrow 
stromal cells’ spread and proliferation, as well as expression of osteoblastic phenotype 
(Barrias et al., 2005). Sahoo et al. (2005) prepared various porous PLGA and 
polylactide (PLA) microspheres containing hydrophilic polymers poly(vinyl alcohol) 
(PVA) and evaluated their physical properties. Their results indicated that the cells 
showed better adhesion and growth on PLA-PVA microspheres due to the compatible 
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structure. Taken together, microsphere scaffolds made from synthetic polymers are 
good substrates to support cell growth and preserve the specific phenotypes. However, 
most synthetic polymers lack the ability to interact with cells specifically. Surface 
conjugation with extracellular matrix proteins and peptides are effective approaches to 
improve the surface biocompatibility. Hong et al. (2005) prepared PLA microspheres 
with larger amount of collagen on their surfaces by a method of aminolysis and 
grafting-coating. In vitro chondrocyte culture demonstrated that this surface 
modification is effective in making the microsphere more conductive to chondrocyte 
cells. Instead of natural proteins, Chen et al. (2006) modified poly(L-lactide) (PLLA) 
microspheres with RGDDSPK, a short peptide chain which can bind with the integrin 
receptors on cell membrane. Their results showed improved cell-matrix interactions.  
In summary, the microsphere is a versatile scaffold which can assemble into 
various shapes suitable for different tissue applications, and it also offers easy and 
controllable surface modification for enhanced cell-scaffold interaction. However, the 
studies of microspheres as scaffold are still quite limited, especially on liver tissue 
engineering. Therefore, the use of microspheres to engineer liver tissue will be further 
explored in this project.  
2.3.3 Biomaterials for scaffold 
2.3.3.1 Natural and synthetic polymers 
Besides the scaffold’s bulk physical properties, the scaffold material is equally 
important. A variety of materials have been studied for tissue engineering purpose, 
including degradable polymer (Langer, 1999; Pachence and Kohn, 2000) and non-
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degradable ceramic materials (Rodriguez-Lorenzo and Ferreira, 2004). Among them, 
biodegradable polymers are the most widely used.  
Biodegradable polymers can be gradually degraded through hydrolysis of the 
polymer backbone with the help of water or enzymes secreted by cells. They are 
broadly classified as synthetic and natural polymers. 
Natural polymers widely used in tissue engineering scaffolds include collagen 
(Wallace and Rosenblatt, 2003), chitosan (Li et al., 2003), alginate (Dvir-Ginzberg et 
al., 2003), PHB and PHBV (Hu et al., 2003). One advantage of natural polymers is 
good biocompatibility. For example, as the major ECM component, collagen-derived 
scaffolds improve cell adhesion and functionality (Pachence and Kohn, 2000). The 
degradation products of natural polymers are non-toxic small molecules which can be 
converted into carbon dioxide and water over a period of time and removed by 
metabolic activity. However, poor control over the mechanical properties, molecular 
weight and biodegradability in addition to limited supply and high cost are the 
disadvantages for using natural polymer. 
Synthetic polymers, on the other hand, are becoming increasingly popular in tissue 
engineering due to the ease of controlling the chemical and physical structure, 
degradation rate, and hydrophobicity, as well as low cost. Furthermore, they can be 
processed into scaffolds with complex shapes easily, and the surface or porosity of the 
scaffold can be modified without changing the polymer properties. The disadvantages 
are lack of intrinsic biological activity and possible production of toxic degradation 
products. The products may also change the local microenvironment dramatically, 
such as lowering the pH, which can affect cell growth and function. Some widely used 
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synthetic polymers in tissue engineering are poly (ε-caprolactone) (PCL) (Coombes et 
al., 2004), PLA (Sahoo et al., 2005), and copolymer (PLGA) (Newman and McBurney, 
2004; Mercier et al., 2005; Sahoo et al., 2005). PLA and PLGA have been the most 
widely used synthetic aliphatic polyesters in medical applications since they received 
the approval from the US Food and Drug Administration (FDA).   
2.3.3.2 PHB and PHBV 
Poly (3-hydroxybutyrate) (PHB) and poly (3-hydroxybutyrate-co-3- hydroxyvalera 
te) (PHBV) are microbial polyesters produced by bacteria (Avella et al., 2000). The 
molecular structures of PHB and PHBV are shown in Figure 2.3. As natural polymers, 
PHB and PHBV received great interests in medical applications because of their 
biocompatibility, biodegradability and non-cytotoxicity (Sendil et al., 1999; Köse et al., 
2003).  
 
Unlike other natural polymers, the physical properties of PHBV can be controlled 
by varying the fractions of HV, which can be achieved easily by adjusting the growth 
environment of bacteria (Avella et al., 2000). For example, with the increase of the 
Figure 2-3. Molecular structure of PHBV: (a) PHB and (b) PHV. 
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PHV composition, the glass transition temperature (Tg), melting temperature (Tm) and 
crystallinity of PHBV decrease. By varying copolymer composition, the molecular 
weight and degradability were found to vary widely too (Thwin, 2004). Compared 
with the widely used synthetic copolymer PLGA (50:50), the degradation rate of 
PHBV is slower. Both of PLGA and PHBV are polyesters which will produce organic 
acids as degradation products, which will lower the pH value around the tissue 
dramatically and kill healthy cells. Lower degradation rate may allow the exchange of 
the acids by the metabolic system in time and keep the local pH unchanged.  
A number of studies have shown that PHB and PHBV are suitable materials for 
drug delivery and biomedical application. Sendil et al. (1999) loaded tetracycline, an 
antibiotic, into PHBV microspheres of three valerate contents (7, 14, and 22% molar 
ratio) using a water in oil in water (w/o/w) double emulsion technique. The 
encapsulation efficiency (EE), drug loading, release characteristics, and morphology 
were investigated. They concluded that the EE of neutralized tetracycline was much 
higher than in acidic conditions and the release behavior fitted Higuchi’s approach for 
microsphere release well. Doyle et al. (1991) evaluated degradation properties and 
biocompatibility of PHB and PHB reinforced by hydroxyapatite both in vitro and in 
vivo. They reported that the degradation rate was a function of the composition and the 
materials did not cause any undesirable chronic inflammatory response after 
implantation in rabbits for up to 12 months. PHBV rods encapsulated with antibiotics 
did not elicit an inflammatory response when implanted into rabbit tibia, which 
indicated good in vivo biocompatibility (Gürsel et al., 2001). PHB patches were 
reported to promote the regeneration of atrial septum at defect sites after the patches 
were implanted into six calves for 12 months. In addition, no shunt or signs of 
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infection were found (Malm et al., 1992). Despite all these studies, compared to the 
more commonly used polyester PLGA, PHBV has many similar properties but has 
been less studied for use as tissue engineering scaffolds. 
2.4 Surface Modification of the Scaffold 
Surface modification of the scaffold can improve its biocompatibility and create 
appropriate biomimetic environment to regulate cell growth, which is crucial for the 
success of tissue engineering.  
2.4.1 Cell interaction with the surface of the scaffold 
For anchorage-dependent cells, adhesion to the surface of scaffold is critical 
because it precedes other events such as cell proliferation, migration and function 
(Saltzman, 2000). The mechanism of cell adhesion to substrates has been explained by 
two theories: (1) physicochemical theory which refers to passive adhesion including 
hydrophobic interaction, electric and ionic interaction; and (2) biological theory which 
refers to active adhesion mediated by receptors on cell membranes and cell adhesive 
molecules on the substrates (Curtis and Lackie, 1991). Cell aggregation is also 
important in tissue engineering because it can promote cell-cell interaction which often 
enhances cell function and viability. It has been reported that certain surface 
modification method resulted in the formation of hepatocytes aggregates, which 
resemble what cells form in vivo, and thus exhibit cell specific functions (Li et al., 
2003).  
Many studies were done on surface modification techniques to change surface 
properties such as wettability (Khang et al., 2002), surface charge (Wan et al., 2003), 
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functional groups (Li et al., 2003; Chua et al., 2005), as well as to introduce cell-
adhesive ligands (Jun and West, 2004; Bartolo et al., 2005;  Biltresse et al., 2005). 
2.4.2 Surface modification of polymeric substrate 
2.4.2.1 Surface oxidation to change the wettability 
Hydrophilicity is one of the most important factors which determine cell adhesion 
to surfaces. It is believed that cell adhesion appears to be optimal on surfaces with 
intermediate wettability (Saltzman, 2000). Surface oxidation by acids or bases can 
introduce oxygen-based functional groups such as carboxyl, carbonyl and hydroxyl 
groups, which have been demonstrated to enhance hydrophilicity effectively. Also, the 
introduced functional groups have the potential to react with other bioactive molecules 
such as Arg-Gly-Asp (RGD) and Tyr-Ile-Gly-Ser-Arg (YIGSR) to further enhance 
surface biocompatibility. Khang et al. (2002) investigated the effect of chemical 
(chloric acid, sulfuric acid, and sodium hydroxide) and physical treatments (corona and 
plasma discharge) on PLGA (75:25) films. The results indicated that the water contact 
angles of surface-treated PLGA films decreased from 73° to 50°–60°.  
2.4.2.2 Immobilization of cell adhesive proteins and peptides onto the surface 
Essential ECM proteins such as collagen, laminin, fibronectin and vitronectin, are 
referred to as cell adhesive proteins because they can interact with the integrin 
receptors on cell membranes (Figure 2-4). These proteins can be immobilized on the 
scaffold surface by simple coating or covalent grafting, providing cells with a mimetic 
microenvironment (Hubbell, 2000; Ku et al., 2005). Sanchez et al (2000) investigated 
how different ECM proteins affect the morphology, growth and differentiation of rat 
hepatocytes. They found that all of the proteins improved cell attachment to a similar 
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extent while cells exhibited a cord-like structure only when cultured on fibronectin 
coated petri-dishes. The cells also expressed liver specific genes to greater extents. 
However, Mooney believed that regardless of the type of ECM proteins, the densities 
at which they were presented to the cells might be the key in controlling hepatocytes’ 
phenotype (Mooney et al., 1992).   
 
  
Although grafting ECM proteins onto the scaffold surface is an effective way to 
mediate cells attachment, several reports have demonstrated that the integrin receptors 
bind specific sequences in the cell adhesive proteins, such as the tripeptide RGD and 
the pentapeptide YIGSR, which are called the cell adhesive peptides (Bhadriraju and 
Hanse, 2000; Massia and Stark, 2001;  Merrett et al., 2001). Compared with the 
proteins, short cell adhesive peptides can be coupled at high density onto the scaffold 
surface, are easier to characterize, and are available at a lower cost. Carlisle et al. 
(2000) grafted RGD and YIGSR peptides onto the surfaces of PCL and PLLA 
substrates by the pulsed plasma deposition technique. Surface density, quantified by 
radio-iodinated tyrosine in YIGSR, were 158 fmol/cm2 on PLLA and 425 fmol/cm2 on 
PCL surfaces. Hepatocytes adhesion was significantly enhanced on both RGD and 
Figure 2-4. Cell adhered on polymer surfaces mediated by cell adhesive 
molecules and integrin receptors. 
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YIGSR modified PCL surface, while only RGD-modification improved cell adhesion 
on PLLA surface. Massia et al. (2001) covalently immobilized three synthetic peptides, 
GRADSP (inactive control), GRGDSP (linear) and GpenGRGDSPCA (cyclic) on 
surface-grafted dextran by a nontoxic aqueous method. In vitro endothelial cell, 
fibroblast and smooth muscle cell attachment results indicated that surface-grafted 
cyclic RGD peptides promoted cell adhesion while inactive peptides did not. 
According to Rezania et al. (2000), a surface density higher than 0.62 pmol/cm2 of a 
fifteen amino acid peptide (containing RGD) significantly enhanced the mineralization 
of ECM by osteoblasts.  
2.4.2.3 Immobilization of carbohydrates onto the surface 
Besides the integrin receptors, hepatocytes have a specific asialoglycoprotein 
receptor (ASGP-R), which promotes the removal of glycoproteins from the blood 
circulating in the liver (Watanabe et al., 2000). ASGP-R can recognize several 
carbohydrate-based substances such as galactose, lactose and fructose in a calcium ion-
dependent manner. Therefore galactose or fructose moiety immobilized onto polymer 
surfaces as specific ligands to hepatocytes has been widely investigated in liver tissue 
engineering to enhance liver cell adhesion and promote hepatic functions. Li et al. 
(2003) investigated rat hepatocytes growth in fructose-modified chitosan scaffold. 
They found a much larger number of hepatocytes attaching onto the modified scaffold 
and the cells exhibited a round cellular morphology. Scanning electron microscope 
(SEM) images confirmed the observation of cellular aggregates formation on the 
modified chitosan scaffold. In addition, albumin secretion and urea synthesis were 
significantly increased when the cells were cultured on the fructose-modified scaffold. 
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The advantages of using carbohydrates include a much lower cost, no risk of viral 
transfer and more permanent activity. However, it is also reported that the binding 
forces between receptors and carbohydrates are much weaker than those of peptides 
(Hersel et al., 2003).  
2.5 Delivery of Growth Factor for Tissue Engineering  
In tissue engineering, growth factors are essential to promote cell proliferation, 
differentiation and to induce vascularization. However, direct administration of these 
molecules is not always applicable due to poor in vivo stability as a result of 
proteolysis (Babensee et al., 2000; Tabata, 2000; Saltzman and Olbricht, 2002; Chen 
and Mooney, 2003). A localized delivery system which can maintain the bioactivity of 
growth factors as well as provide to the cells with the molecules without the dilution 
effect in solution is therefore necessary. 
2.5.1 Growth factors and criteria for delivery systems 
Growth factors are small molecular proteins which are secreted by various types of 
cells. Through binding to receptors on the target cells, growth factors can regulate cell 
migration, differentiation and proliferation. Growth factors act in a concentration, 
spatial and time dependent manner and have been widely applied in surgical 
procedures including skin regeneration, bone induction and vascularization.  
Skin and wound healing was the first area where growth factor-based 
pharmaceutical therapy was applied. The growth factors which have been identified as 
mediators of skin and wound regeneration include platelet-derived growth factor 
(PDGF), epidermal growth factor (EGF) and transforming growth factor (TGF-α, 
TGF-β) (Deuel and Zhang, 2000). Other growth factors such as bone morphogenetic 
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protein-2 (BMP-2) and osteogenic proteins (OP-1 or BMP-7) can induce the 
infiltration of the osteoblasts from the surrounding healthy tissues into the implanted 
devices and have been clinically used to treat patients with bone diseases. Furthermore, 
vascular endothelial growth factor (VEGF165), basic fibroblast growth factors (bFGF), 
angiopoietins-1 and 2 (Ang-1 and Ang-2) play a key role in the formation of new 
blood vessels which are critical for curing vascular diseases in tissue engineering. A 
list of commonly used growth factors in tissue engineering and their know activities is 
given in Table 2-1 (Chen and Mooney, 2003). 
Although growth factors clearly play an important role in tissue regeneration, it is 
a challenge to deliver the molecules to the desired sites in an appropriate mode. Direct 
injection is not always feasible because the half-life (several minutes to several hours) 
of most growth factors in the human body is too short for them to exhibit their effects. 
Moreover, the distribution of the growth factors throughout the body, resulting from 
bolus delivery, may lead to undesirable side effects (Tabata, 2000; Chen and Mooney, 
2003). Researchers should keep several important considerations in mind when 
designing a growth factor delivery system for tissue regeneration: (1) identifying the 
biologic activities of the growth factors for a particular tissue application; (2) 
delivering the molecules to desired cells or tissues and avoiding signal propagation to 
non-target cells; (3) long-term delivery with well-maintained bioactivity of the growth 
factors; and (4) delivery with a temporal and spatial mode (Babensee et al., 2000). 
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Migration, proliferation, and 
survival of endothelial cells 
* Adapted from (Chen and Mooney, 2003) 
 
Table 2-1. A list of growth factors commonly used in tissue engineering* 
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2.5.2 Polymeric delivery system for growth factor 
The use of polymeric particles for localized delivery of anti-cancer drugs has been 
widely studied for many years (Langer, 1999; Wang et al., 2002) and it has also been 
proved to be able to deliver growth factors at an appropriate time profile to stimulate 
cell growth for the tissue regeneration (Cao and Shoichet, 1999; Holland et al., 2005; 
Defail et al., 2006).  
Ishihara et al. (2003) incorporated FGF-1, FGF-2, VEGF165 and HB-EGF into 
photo-crosslinked chitosan hydrogels. The in vitro release results indicated that 10-
25% of growth factors were released within the first day while no further substantial 
release took place. The growth factors interacted with the chitosan hydrogel to form 
polyion complexes, and could not be released without degradation. They also observed 
that addition of heparin with either FGF-1 or FGF-2 resulted in a significantly 
enhanced and prolonged vascularization effect. According to Perets et al. (2003), 
releasing of bFGF from PLGA microspheres largely induced the penetration of 
capillaries into the porous alginate scaffolds, which was shown by the massive layer of 
mural cells surrounding endothelial cells. Peters et al. (1998) also demonstrated that 
VEGF released from alginate microspheres stimulated endothelial cell growth 
effectively in vitro. Oe et al. (2003) injected hepatocyte growth factor (HGF)-
incorporated gelatin microspheres into the livers of rats. Compared with free HGF and 
HGF-free gelatin microsphere, gelatin microspheres incorporating HGF effectively 
promoted the rats’ recovery from liver fibrosis as well as liver regeneration. 
However, one big challenge of growth factor delivery technology is the loss of 
biological activity caused by protein denaturation and deactivation during their 
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incorporation into the polymer matrix (Tabata and Ikada, 1998). High temperatures, 
strong mechanical mixing and use of organic solutions are potential factors which 
contribute to the loss of activity of proteins. Therefore, it is necessary to employ a 
feasible way to enhance the encapsulation efficiency as well as minimize denaturation 
of growth factors. Tabata et al. (1999a, 1999b, 1999c) prepared bFGF-incorporated 
gelatin microspheres using a surfactant-free process. Based on different isoelectric 
points (IEPs), positively or negatively charged gelatin molecules interacted with 
oppositely charged protein molecules to form a polyion complex. The bFGF-
incorporated gelatin microspheres effectively promoted the formation of new blood 
vessels and accelerated bone regeneration after implantation, which proved the 
maintenance of biological activity of the growth factor. 
In a tissue engineering system, it would be ideal if the scaffold which functions as 
a substrate for cell to attach could be able to simultaneously deliver suitable growth 
factors in a controlled manner to stimulate cell growth and new vessel formation at the 
implantation sites. However, it is not always possible to encapsulate growth factors 
directly into the scaffolds due to the complex structures and fabrication process. One 
solution is to initially encapsulate the growth factors into microspheres, and the 
microspheres can then be incorporated into the scaffolds (Holland et al., 2005; Defail 
et al., 2006). Among the many types of scaffolds studied, microspheres have been 
found to offer a number of exciting advantages for tissue regeneration (Barrias et al., 
2005; Mercier et al., 2005; Sahoo et al., 2005). Microspheres provide 3D environments 
which can better preserve the phenotype of the cells (Malda et al., 2003). Also, growth 
factors can be encapsulated into the microspheres and released with controllable 
delivery profiles. Therefore, the use of polymeric microsphere as a scaffold, which can 
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deliver growth factor directly to the cells grown on it, could be advantageous to 
producing a viable tissue engineering system.  
2.6 Vascularization for Tissue Engineering 
One of the major obstacles in engineering large tissues in vitro is the insufficient 
supply of nutrients and oxygen to the cells growing inside the scaffold (Griffith et al., 
2005). Vascularization of the scaffolding system, which can maintain the viability of 
the cells as well as improve the structural integrity of the engineered tissue, is a 
prerequisite for the success of engineering large tissues (Frerich et al., 2001; 
Levenberg et al., 2005). 
2.6.1 Microvasculature and in situ remodeling 
Microvasculature begins with arteries dividing consecutively into smaller branches 
consisting of meta-arterioles (80-100 µm) and capillaries (10-15 µm). These vessels 
serve to distribute blood and nutrients whilst lowering the pressure head. In addition, 
the system allows for a more efficient exchange of metabolites (Levick, 2000).  
The vascular tree is formed during early gestation. Angiogenic cells form clusters 
which coalesce to form solid tubes, and eventually canalize to form blood vessels 
(Buschmann and Schaper, 2000). The outer ring consists of angioblasts which form the 
vessel walls. The subsequent differentiation of these precursor angioblasts into 
endothelial cells and the de novo formation of a vascular network are termed 
“vasculogenesis”. These vessels are capillary-like initially and eventually differentiate 
into either arteries or veins (Murohara, 2001). The adult vascular network remodels 
itself by arteriogenesis with enlargement of existing collaterals, as well as formation of 
completely new vessels from existing vessels (Peirce and Skalak, 2003). Micro-
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vascular remodeling is a mechanistic process which frequently occurs in a fibrin-rich 
extracellular matrix. Through binding with the ligands (RGD) on the α-chain of 
fibrinogen, endothelial cells adhere and spread on the matrix to form capillary-like 
tubules (Nehls and Herrmann, 1996). It is believed that the new capillaries induced 
from the microvascular network play a crucial role in organ development and wound 
healing. 
2.6.2 Vascularization of scaffold-based system 
Although tissue engineering shows great potential to restore function to almost 
every tissue, the most successful applications to date have been limited to thin tissue 
equivalents such as skins in which nutrients could be delivered by diffusion (Frerich et 
al., 2001). For thick and more complex tissue equivalents such as muscles and liver, 
diffusion alone would not be sufficient to provide oxygen and nutrients to cells 
growing in the deeper sections of the scaffolds, thus resulting in the ultimate failure of 
the engineered tissue (Levenberg et al., 2005). For example, the lack of sufficient 
blood supply is believed to be the primary reason for cell death that occurs in 
hepatocyte transplantation. Therefore, a vascularized scaffold-based system which can 
provide nutrient and oxygen to maintain cell viability might be a prerequisite for the 
success of engineering large tissues.  
Vascularization of engineered tissue constructs in vivo can be achieved by 
implanting the scaffold into the body and permitting the growth of blood vessels into 
the matrix. This can be further stimulated with the administration of angiogenic factors, 
such vascular endothelial cell growth factor (VEGF) and basic fibroblast growth factor 
(bFGF) (Tabata and Ikada, 1998; Riley et al., 2006). However, it is more complicated 
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to vascularize the scaffold in vitro, and this is perhaps the biggest challenge faced by 
tissue engineers. Frerich and co-workers developed a soft tissue model consisting of 
micro-carriers covered with adipose tissue stromal cells which were then mixed with 
endothelial cells in a fibrin matrix in vitro. Capillary-like structures were observed 
under confocal microscope after 8 days of culture (Frerich et al., 2001). In a recent 
work, Levenberg and co-workers added embryonic fibroblasts into a co-culture system 
consisting of myoblasts and endothelial cells on porous PLGA scaffold. The addition 
of fibroblast promoted the formation of vessels in vitro, and the prevascularized 
scaffold improved in vivo vascularization after transplantation (Levenberg et al., 2005). 
Although there are many factors affecting the formation of blood vessels in vitro, 
culturing endothelial cells on appropriate 3D scaffolds is believed to be the basis and 
premise for the success of vascularization (Nehls and Herrmann, 1996). Furthermore, 
it is well known that several growth factors such as bFGF, VEGF165 and platelet-
derived growth factors can stimulate the rapid formation of capillary vessels (Babensee 
et al., 2000; Tabata, 2000). However, the effects of the growth factors by direct 
administration or injection were found to be insignificant because of their poor 
stability resulting from proteolysis (Chen and Mooney, 2003). Therefore, a localized 
delivery system which can maintain the bioactivity of growth factors for an extended 
period of time might be necessary in promoting the formation of blood vessels.  
 
2.7 Summary 
Tissue engineering shows great promise to regenerate damaged tissues and solve 
the problem of organ donation shortage. Although investigators have attempted to 
Chapter 2 
 
33                        
   
 
engineer various mammalian tissues such as skin, bone, cartilage, tendon and muscles, 
the research on complex organs such as the liver is still in its infancy. The biggest 
challenges are the quick dedifferentiation of primary hepatocytes resulting in the loss 
of normal liver functions, and the death of the cells due to the lack of sufficient oxygen 
and nutrient supply when cultured in vitro. Therefore, a novel scaffolding system 
which could provide proper environment (3D environment, biocompatible surface, 
growth factors release and vascular networks) to preserve the phenotype as well as 
provide enough nutrients to the cells the maintain their viability is necessary for the 
success of engineering a liver tissue, which is the motivation of this project.  
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Chapter 3 Fabrication and Characterization of 




As temporary replacement of extracellular matrix (ECM) to support the growth of 
the cells, polymer scaffolds play an essential role in tissue engineering. The scaffold 
should not only act as a substrate for cells to attach, but also provide desirable 
microenvironment such as biocompatible surface and controllable delivery of growth 
factors to improve the proliferation as well as preserve the phenotype of the cells. The 
scaffold should also provide flexible structures for easy implantation and match the 
irregular shapes of defects or complex architecture of organs. Microspheres have been 
traditionally used as drug delivery vehicles or carriers to harvest cells. The unique 
three-dimensional (3D) environment offered by microspheres can improve cells’ 
proliferation and preserve their differentiated functions. Microspheres have also been 
demonstrated for application in tissue engineering to deliver bioactive molecules such 
as growth factors and genes. However, using microspheres as scaffold for tissue 
engineering is a new idea which needs further exploration. Poly (3-hydroxybutyrate) 
(PHB) and poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) are microbial 
polyesters produced by bacteria. PHB and PHBV received great interests in the 
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applications for drug delivery and tissue engineering because of their biocompatibility, 
biodegradability and non-cytotoxicity. 
In this chapter, PHBV microspheres with three size distributions were fabricated 
using an emulsion solvent evaporation technique. The fabricated microspheres were 
characterized by particle size analyzer and a scanning electron microscope (SEM). 
Human hepatoma cell lines, HepG2 and Hep3B which were chosen as models of 
primary human hepatocytes, were cultured on the microsphere scaffold. The 
proliferation of the cells and two liver functions, albumin secretion and cytochrome P-
450 activity were quantitatively measured. The objectives were to determine the 
optimum scaffold dimension to guide the growth of liver cells and also to compare the 
functions of the two human hepatoma cell lines cultured on the scaffold.  
3.1 Materials and Methods 
3.1.1 Materials 
Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) copolymer (PHBV, 8% PHV), 
Tween®80, Tween®20, sodium pyruvate, antimycotic solution, poly(L-lysine), 
Phosphate-buffered saline (PBS) (pH=7.4), HEPES-buffered saline solution (HBSS) 
(pH=7.4), paraformaldehyde, saponin, phalloidin-FITC, DAPI, glutaraldehyde (GTA), 
dimethyl sulfoxide (DMSO), 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-
tetrazolium bromide (MTT), bisbenzimide (Hoechst 33258), trypsin, Tris-HCl 
(pH=7.4), sodium chloride, ethylenediaminetetraacetic acid (EDTA), bovine serum 
albumin (BSA), 7-ethoxyresorufin, dicumarol, sodium resorufin, ethanol, and trapan 
blue were purchased from Sigma-Aldrich (St. Louis, MO, USA). Chloroform was 
purchased from Fluka (Steinheim, Germany). Poly (vinyl alcohol) (PVA) (MW 6000) 
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was purchased from Polysciences (Warrington, PA, USA). Dulbecco’s modified eagle 
medium (DMEM) was purchased from Gibco (USA). Fetal bovine albumin (FBS) was 
purchased from Hyclon (UT, USA). Laminin was purchased from Invitrogen (USA). 
Live/dead kit was purchased from Molecular Probes (Eugen, OR, USA). Lysis buffer 
was from Promega (San Luis Obispo, CA, USA). Human albumin enzyme-linked 
immunosorbent assay (ELISA) quantification kit was purchased from Bethyl (Texas, 
USA). HepG2 and Hep3B cells were purchased from American Type Culture 
Collection (ATCC, Virginia, USA). All chemicals were used directly without further 
purification.  
3.1.2 Fabrication of microspheres 
A water-in-oil-in-water (w/o/w) emulsion solvent evaporation technique was used 
to fabricate PHBV microspheres (Yang, et al., 2000). Briefly, 0.6 g of PHBV (8%) 
powder was dissolved in 12 mL of chloroform, and then 1 mL of phosphate-buffered 
saline (PBS) (pH=7.4) with 0.05 w/v% poly(vinyl alcohol) (PVA) was added. 
Emulsification was subsequently carried out using a homogenizer (T25B, Ika 
Labortechnik, Staufen, Germany) for 15s. Several homogenizing speeds, 16000 rpm, 
19000 rpm and 22000 rpm were applied to get different size distributions of 
microspheres. The homogenized mixture was immediately poured into 300 mL of PBS 
with 0.05 w/v% PVA. The solution was then placed under continuous mechanical 
stirring (RW20, Ika Labortechnik, Staufen, Germany) at 300 rpm for 3h to evaporate 
the organic solvent. The temperature was maintained at 37ºC with a magnetic hotplate 
stirrer (Cimarec2, Barnstead/Thermolyne, IA, USA). The microspheres fabricated 
were washed with deionized water 5 times and transferred into a 15 mL glass vial and 
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placed in a freeze dryer (Alpha 1-4, Martin Christ, GmbH, Germany) for 36 hours to 
remove any remaining solvent and water droplet and to get a constant weight of porous 
microspheres. 
3.1.3 Characterization of microspheres 
The size distributions of microspheres produced by different homogenizing speeds 
were measured by a particle size analyzer (Coulter LS-230, FL, USA). Tween®80 was 
used to disperse the microspheres into the water evenly. The external surface 
morphologies of the microspheres were characterized by a scanning electron 
microscope (SEM) (JSM-5600VL, JEOL, Tokyo, Japan). To observe the internal 
structure of the microspheres, samples were sectioned with a cryostat microtome 
(Leica CM3050S, Germany) with blade step setting at 30 μm and air dried. The intact 
microspheres and cross-sectioned samples were mounted onto brass stubs using 
double-sided adhesive tape and vacuum-coated with a thin layer of platinum using the 
Auto Fine Coater (JFC-1300, JEOL, Tokyo, Japan) for 40 seconds prior to 
examination. The diameters of the internal pores were estimated using a software 
Smile View. 
3.1.4 Cell culture and cell seeding on microspheres 
Human hepatoma cell lines, HepG2 and Hep3B (American Type Culture 
Collection, ATCC), were selected as models for the culture of primary hepatocytes. 
The cells were cultured in DMEM medium supplemented with 10% FBS, 110 mg/L 
sodium pyruvate and 1% antimycotic solution. The cells were maintained in T-75 
flasks in an incubator at 37ºC in the presence of 5% CO2 and 95% relative humidity. 
The medium was renewed every 3 days. 
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Five milligrams of microspheres with a total surface area around 2.5 cm2 were 
sterilized in a 2 mL centrifuge tube using 70% ethanol followed by completely 
washing with sterilized PBS. The tube was then placed in an incubator with culture 
medium for 3 hour at 37°C to let the microspheres stabilize at the bottom. Cells were 
subsequently seeded at 2.5 × 104 cells/mL into the tube, or approximately 1×104 
cells/cm2 of microsphere surface. The microspheres with attached cells were 
transferred to 24-well tissue culture plates after 1 hr incubation. The cells attached on 
the microspheres were counted by a trypan blue exclusion method to estimate the 
seeding efficiency (Jacobson and Ryan, 1982).  
To prepare the positive control, 200 µL of 1 mg/mL poly(L-lysine) aqueous 
solution was added to each well of a 24-well plate and the plate was incubated for 2 
days at room temperature. Then, 100 μL of a 0.5 mg/mL aqueous solution of laminin 
was added and incubated overnight at 37ºC. Polyurethane film containing 0.1% zinc 
diethyldithiocarbamate (ZDBC) was used as the negative control. 
3.1.5 Morphology of cell-microsphere constructs 
Optical microscope: The morphologies of cells and cell-microsphere construct 
were observed under optical microscope (Leica DMIL, GmbH, Germany). Images 
were taken by a digital camera (OICAM Fast 1394, OIMAGING, Canada) connected 
with the microscope at different days of culture.  
CLSM images: (1) Live/Dead assay: The viability of cells cultured on 
microsphere scaffold was assessed using a live/dead kit which contains two 
components, SYTO 10 green fluorescent nucleic acid stain and DEAD Red (ethidium 
homodimer-2) nucleic acid stain. Briefly, the cell-microsphere constructs were washed 
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with HBSS buffer and incubated in 200 µL of live/dead solution in dark for 30 min at 
room temperature. The dye solution was then removed. The cell-microsphere 
constructs were washed with fresh HBSS and fixed with 4 v/v% glutaraldehyde in 
HBSS (freshly prepared) for at least 15 minutes before observation. A confocal 
micrograph was obtained by using a confocal laser scanning microscope (CLSM) 
(Leica, DM-IRE 2, Germany). The fluorescent green-colored indicated live cells while 
the fluorescent red-colored cells were dead cells. 
(2) Nucleus/Actin double staining: The cell-microsphere constructs were washed 
twice with PBS and fixed with 4 v/v% paraformaldehyde in PBS for 30 min. The 
samples were then washed with PBS and the cells were permeabilized with 0.2% 
saponin for 15 mins. After being washed with PBS, the cell-microsphere constructs 
were stained with phalloidin-FITC (1:200) for 1 hour. The samples were washed three 
times with PBS and counter stained with DAPI (1: 10,000) for 5 minutes. A confocal 
micrograph was obtained by using a CLSM (Leica, DM-IRE 2, Germany). The 
fluorescent green-color indicated actin of the cells while the fluorescent blue-color was 
the nucleus. 
SEM images: For SEM imaging, cell-microsphere constructs were washed twice 
with PBS and fixed with 2.5 v/v% glutaraldehyde (GTA) in PBS in a 24-well plate for 
1 hr. The samples were then washed twice with PBS and dehydrated using a graded 
series of ethanol (50%, 60%, 70%, 80%, 90%, and 100 v/v%) (Jacobson and Ryan, 
1982). Samples were air dried and mounted onto an aluminum stub and sputter-coated 
with platinum for 40 s before viewing under SEM.  
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3.1.6 Cell proliferation and functionality 
3.1.6.1 MTT quantification 
The MTT assay is based on the cleavage of a water-soluble yellow methylthiazol 
tetrazolium (MTT) salt to water-insoluble purple formazan crystals by the action of 
dehydrogenase enzymes, which are produced by living cells. The amount of the 
formazan formation can be measured spectrophotometrically, where the absorbency 
measurement is directly proportional to the number of living cells (Carlisle et al., 
2000). At different days of incubation, the MTT assays were carried out to measure the 
cells viability. Briefly, the cell culture medium was removed firstly. The cell-
microsphere constructs were then washed with sterilized PBS. 0.9 mL of serum-free 
cell culture medium and 0.1 mL of MTT solution (5mg/mL) were added into each well 
and incubated at 37ºC for 4 hours. The culture medium was removed and washed with 
PBS. The formazan was then dissolved in DMSO and the absorbance was measured at 
wavelength of 560 nm as measurement and 620 nm as reference by a Microplate 
Reader (Tecan GENios, Switzerland). 
3.1.6.2 Total DNA quantification 
Cellular DNA content was quantified using bisbenzimide (Hoechst 33258) 
fluorescence assay (Rago et al., 1990). Briefly, cell-microsphere constructs were rinsed 
twice with PBS solution and were lysed for two hours in 200 µL of a lysis cocktail 
containing 0.25 v/v% trypsin and 2.5 v/v% lysis buffer in ultra-pure water followed by 
three freeze-thaw cycles. The cell lysates were mixed with 1 µg/mL bisbenzimide in 
10 mM Tris-HCl (pH 7.4), 1 mM EDTA and 0.2 M NaCl fluorescence assay buffer 
and were incubated in dark for 30 minutes. The fluorescence was read using a 
Chapter 3 
 
41                        
   
 
microplate reader (Tecan GENios) with 360 nm as excitation wavelength and 465 nm 
as emission wavelength. 
3.1.6.3 ELISA assay to quantify albumin secretion 
The albumin secretion of liver cells was measured by ELISA, which is based on 
the antibody-sandwich mechanism (Glicklis et al., 2000). Since the Hep3B cells are of 
human origin, the bovine albumin from the serum media should not react with the anti-
human albumin affinity. According to the protocol of the ELISA, blocking solution (50 
mM Tris, 0.14 M NaCl, 1% BSA, pH 8.0) was used to block the non-specific area and 
sample diluent (50 mM Tris, 0.14 M NaCl, 1% BSA, 0.05% Tween 20, pH 8.0) was 
used to dilute the samples. Since both of these two solutions contain 1% BSA, the 
BSA from cell culture medium was believed to have no cross reactivity in the ELISA 
assay and will not affect the final results. At the desired days of culture, 0.5 mL of the 
supernatant was aspirated from the wells and centrifuged at 13000 rpm for 5 min, 
filtered with 0.25 µm millipore filter and stored at –20ºC until required for analysis.  
3.1.6.4 Cytochrome P-450 activity by EROD assay 
The P-450 (CYP1A1/2) activity represents the detoxification ability of liver cells, 
which was measured by an ethoxyresorufin-o-dealkylase (EROD) assay (Bhandari et 
al., 2001). At the desired days of culture, after the culture medium was aspirated and 
stored for ELISA test, the cell-microsphere constructs were rinsed twice with sterilized 
PBS solution. One milliliter of PBS solution containing 5 µM 7-ethoxyresorufin and 
10 µM dicumarol was then added into each well and incubated for 3 hours at 37ºC in 
the dark. The fluorescence of the supernatant was measured using a microplate reader 
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(Tecan GENios) with 535 nm as excitation wavelength and 595 nm as emission 
wavelength. The standard curve was obtained from resorufin sodium salt solutions. 
3.1.7 Statistical analysis 
All data are presented as mean ± standard deviation and were analyzed by a one-
way ANOVA test, where the symbol “*” on the bars of the positive control indicate 
significant difference with all of the samples to the positive control. Student’s t-test 
was also carried out to do statistical comparisons between pairs of samples. 
Differences between the groups were considered statistically different when p<0.05. 
3.2 Results and Discussion 
The use of micro-carriers to harvest cells has been studied widely since the 3D 
environment offered by micro-carriers can improve cell proliferation as well as 
preserve the differentiated functions. However, using microspheres as scaffold for 
tissue engineering is a new and different idea which so far only a few studies have 
reported. For tissue engineering purposes, the microspheres firstly act to provide a 
surface to support cell growth in vitro. When a tissue-like cell-microsphere construct is 
formed with certain functions, it will be implanted into the defect tissue to recapitulate 
the desired function and regenerate the defect as the microspheres degrade. Therefore, 
the in vivo degradation profile of the microsphere scaffold should match with the 
regeneration rate of the defect otherwise the scaffold would become a hindrance to the 
formation of new tissue.  
HepG2 and Hep3B are well developed liver cell-like cell lines and are widely used 
to model in vitro culture of primary human hepatocytes. Both of these two lines show 
epithelial morphology when adherent growth on solid surface. Besides high 
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proliferation rates, the cells possess biological functions similar to human primary 
hepatocytes and can secrete many hepatocellular products, such as albumin, transferrin, 
alpha fetoprotein and so on (ATCC).  
3.2.1 Fabrication and characterization of PHBV microspheres 
Three size distributions of microspheres were fabricated using different 
homogenizing speeds to study the effects of size and shape of microspheres on liver 
cell proliferation and functions. The mean diameters are 153.2, 242.5 and 361.8 µm 
respectively, and small standard deviations (SD) indicate narrow distributions (Table 
1). It was shown that a faster homogenizing speed yielded much smaller microspheres 
while a slower speed yielded larger ones (Table 3-1). A possible explanation for this 
could be that a higher homogenizing speed mixed the emulsifier (0.05 w/v% PVA) 
with the polymer molecules more thoroughly. Since surfactant micelles acted as the 
repulsive steric entropic force among the molecules, larger relative contact between 
emulsifier and polymer molecule isolated them into smaller microspheres. 
 
Table 3-1. PHBV microspheres obtained from different homogenizing speeds 
Diameter Internal Pore Size Homogenizing Speed 
(rpm) Mean (µm) SD (µm) Mean(µm) SD (µm) 
M1 22000 153.2 31.6 16.3 2.1 
M2 19000 242.5 38.2 17.5 3.2 
M3 16000 361.8 40.1 13.2 1.8 
 
Figure 3-1 shows the internal and external morphologies of PHBV microspheres. It 
can be seen that the microspheres have spherical shapes with uniform sizes, and the 
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surfaces have rough topography with nano-pores. The porous structure of the 
microspheres was induced by the removal of internal water droplets through 
lyophilization, and the average sizes of the internal pores are around 10-20 µm. The 
highly porous structure is a crucial feature of tissue engineering scaffold because the 
pores will benefit the exchange of nutrient, oxygen, cellular signals as well as removal 
of metabolic wastes. Since PHBV is relative hydrophobic, adding 1 mL of PBS (0.05 
w/v% PVA) into the polymer solution following by high speed homogenizing resulted 
in evenly distributed water droplets among the organic phase, and homogeneous pores 
were formed after microspheres were freeze dried [Figure 3-1 (d)]. Although the pores 
are not clearly observed to be interconnected, the nano-pores on the walls of the pores 
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3.2.2 Seeding efficiency of HepG2 cells on PHBV microspheres 
The seeding efficiency (the ratio of cells attached onto microspheres to the initial 
seeded cells) was investigated using trypan blue exclusion method (Figure 3-2). 
Approximately 20-30% of cells attached onto the microsphere scaffold and the highest 
seeding efficiency was found on the smallest microsphere (p<0.05). As HepG2 cells 
are anchorage-dependent, the initial cell adhesion on microspheres is a critical stage 
a b
dc 
Figure 3-1. (a) and (b) SEM images of PHBV microspheres with an average 
diameter of  153.2 µm illustrating their spherical shape and uniform size; (c) 
magnified image of (b) showing a rough surface with nano-pores; (d) cross-
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because it precedes other events, such as cell spreading, proliferation and 
differentiation. Compared to 2D scaffolds such as polymer films, seeding efficiency on 
most 3D scaffolds is generally lower and it is difficult to distribute the cells uniformly 
within the scaffolds (Barrias et al., 2005). In this study, about 20-30% cells were 
seeded onto the microspheres and the cells were distributed relatively uniformly onto 
the scaffolds. 
 
3.2.3 Morphology of cell-microsphere constructs 
3.2.3.1 Optical micrographs 
Optical micrographs of HepG2 or Hep3B cells cultured on PHBV microspheres 
are shown in Figure 3-3. It can be seen that the cells attached and spread on the 
microspheres after two days of culture [Figure 3-3 (a)]. The cells spread over the 
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after 4 days of culture [Figure 3-3 (b)]. From day 8 onwards, the cells bridged more 
and more microspheres together. At the same time, the cells stretched to fill the gaps 
between the microspheres to form multilayers of cells. After two weeks of culture, 
cells were seen to become confluent on the microsphere scaffolds and cell-polymer 
aggregates started to form [Figure 3-3 (d)]. The cell growth on M2 showed a similar 
profile. After two weeks of culture, the cells have spread completely on the 
microspheres and formed multilayers of cells among the microsphere scaffolds as well 
as deposited an abundant amount of ECM-like structures [Figure 3-3 (e)]. However, 
HepG2 growth on M3 were not adequate as the formation speed of tissue-like structure 
was slower than on M1 and M2 and no confluent tissue-like structures were formed 
after two weeks of culture [Figure 3-3 (f)].  
Although cell growth on M3 showed a similar trend to M1 and M2, the formation 
speed of tissue-like structure was slower. One possible reason for this could be that the 
size of M3 was too big for HepG2 cells (10-20 µm in diameter) to bridge the adjacent 
microspheres together to form aggregates. However, it does not mean that the smaller 
microspheres were better. Microspheres which were too small easily settled to the 
bottom of the plates. This allowed the cells to extend to the bottom of plates from the 
microspheres and fix them onto the surface. As a result, no microspheres could be 
bridged together (data not shown). Accordingly, 3D PHBV microspheres, especially 
the size range between 100 µm to 300 µm, are suitable adhesive substrates for in vitro 
culturing HepG2 cells.  
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3.2.3.2 Confocal laser scanning micrographs (CLSM) 
The viability of Hep3B cells cultured on microsphere scaffold was assessed using 
a live/dead assay. The fluorescent green-colored indicated live cells while the 
Figure 3-3. Optical micrographs of HepG2 cells grown on M1 after (a) 2 days, (b) 4 
days, (c) 8 days and (d) 14 days of culture, (e) HepG2 grown on M2 after 14 days of 
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fluorescent red-colored cells were dead cells [Figure 3-4 (a) and (b)]. It can be seen 
that most of the Hep3B cells grown on microspheres were viable although multilayers 
of cells were formed on the scaffold. However, necrosis could occur if cellular regions 
become even thicker. Diffusion alone will not be efficient to provide nutrients and 
oxygen to the cells grown on the deeper sections of the scaffold. Therefore, pre-
vascularization within the scaffolds should be considered to help the exchange of 
nutrients as well as removal of wastes (Perets et al., 2003).  
The actins and nucleuses of the cells were further stained with phalloidin-FITC 
and DAPI to get detail images on how the cells grown on the microsphere scaffolds 
[Figure 3-4 (c) and (d)]. As can be seen, the cells distributed quite evenly on the 
microsphere surface and secreted abundant extracellular matrix components. The 
confocal images indicated that the PHBV microspheres are well-suited in guiding the 
growth of Hep3B liver cells in vitro. 
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3.2.3.3 Scanning electron micrographs 
SEM images of HepG2 and Hep3B cells cultured on M1 as a function of time are 
presented in Figure 3-5 and Figure 3-6. The images show that the surfaces of 
microspheres were covered by cell layers which deposited an abundant amount of 
extracellular matrix components. The arrows indicated that there existed strong cell-
Figure 3-4.CLSM of Hep3B cells grown on M1 after two weeks of culture.
(a,b) Cells were stained with live/dead kit. (c,d) Cell actins were dyed with 
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cell interaction and cell-substratum interaction between cells and the microspheres. 
Similar to the optical micrographs, multilayer of cells formed to bridge the 
microspheres as well as stretched to fill the gaps, producing tissue-like structures. 
Although both HepG2 and Hep3B are liver cell lines, the morphologies of these two 
lines were observed to be slightly different when cultured on PHBV microsphere 
scaffold. HepG2 tended to form multilayer of cells in the gaps between microspheres 
in bridging the microspheres together [Figure 3-5 (c,d)] while Hep3B cells tended to 
spread on the surface and formed confluent monolayer [Figure 3-6 (c,d)]. These could 
be due to the different morphology properties of the two types of cell lines.  
 
 
Figure 3-5. SEM micrographs of HepG2 cells seeded on M1 after (a, b) one week; (c, 
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3.2.3.4 Proliferation of the cells growth on microsphere scaffold 
 
3.2.4 Proliferation of HepG2 cells grown on PHBV microsphere scaffold 
The proliferation of HepG2 cells grown on PHBV microspheres as well as the 
positive control (laminin coated PLL films) and negative control (ZDBC films) were 
quantitatively evaluated by MTT and total DNA quantification during the 12 days of 
culture as shown in Figure 3-7 (a,b). For each time point, absorbance of MTT solution 
from positive control was set as 100%. The ratios of absorbance of MTT solution from 
microspheres or negative control to that of the positive control were used to evaluate 
cell proliferation on the corresponding substrates. It can be seen that the cell 
Figure 3-6. SEM micrographs of Hep3B cells seeded on M1 after (a, b) one week; (c, 
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proliferation on the three types of microspheres were lower than that of the positive 
control at day 2 and day 4 of culture, while after 6 days, the proliferations of the cells 
on three types of microspheres were significantly increased to 150.7%, 145.5% and 
141.3% respectively. From day 6 onwards, cell proliferations increased steadily on the 
microsphere scaffolds. By the last day of culture, the cell proliferations on M1, M2 and 
M3 reached 191.3%, 171.9% and 169.3%. One reason for this is that compared to 2D 
positive control, microspheres have a larger surface area, which allow larger number of 
cell to grow on it. More importantly, it is believed that the shape of the scaffold affects 
cell adhesion, proliferation and function greatly (Malda et al., 2003; Barrias et al., 
2005). Smaller microspheres improved cell-cell interaction and cell-substrate 
interaction (Figure 3-3 to Figure 3-6), which may stimulate cell proliferation. The cells 
would also be more active in aggregate forms. Figure 3-7(a) also indicated that HepG2 
showed much lower proliferation rate on the negative control, where all values was 
lower than 10%. The proliferation of Hep3B cells showed a similar profile (data not 
shown).  
To more accurately quantify the cell proliferation, a total DNA assay was 
conducted. Figure 3-7(b) shows a similar profile of an increase in cellular DNA which 
is indicated by the fluorescence intensity as the MTT results for the cells grown on 2D 
positive control and the M1 samples. T-tests between these two samples show a 
significantly greater amount of cell growth on M1 which confirmed that cell 
proliferation was improved when cultured on 3D microsphere scaffolds.  
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Figure 3-7. Proliferation of HepG2 cells cultured on positive control (     ), negative 
control (     ), M1 (    ), M2 (    ) and M3 (    ) as assessed by (a) MTT assay; (b) total 
DNA quantification. Values represent means ± SD, n=3 (*p<0.05 as compared to 
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2             4            6             9            12 
Figure 3-8. Albumin secretion by (a) HepG2 and (b) Hep3B cells cultured on 
positive control (     ), negative control (     ), M1 (     ), M2 (     ) and M3 (     ). 
Values represent means ± SD, n=3 (*p<0.05 as compared to the positive control 
by ANOVA, +p<0.05 by t-test comparison between the two samples).  
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Albumin production by HepG2 and Hep3B cells cultured on controls and 
microspheres were assessed by ELISA and the results are shown in Figure 3-8 (a) and 
Figure 3-8 (b) respectively. HepG2 cells cultured on microspheres maintained a steady 
increase of albumin secretion throughout the study although there was a slight drop at 
12 days of culture. No significant increases of albumin secretion were found on the 
positive controls. It can be seen that Hep3B cells seeded on microspheres secreted 
albumin 2-4 times more than that on the positive control after 7 days of culture, which 
indicated that this hepatic function was greatly improved by the aggregation of cells on 
microspheres.  
HepG2 and Hep3B cells secreted significantly more albumin when cultured on 
microspheres than on positive control. The results from cell proliferation assays 
indicated that HepG2 cells proliferated faster on microspheres than on the positive 
control (Figure 3-7), and the larger number of cells might secrete a higher amount of 
albumin [Figure 3-8 (a)]. More importantly, it is believed that the cell-scaffold 
aggregate can improve the hepatic functions of liver cells (Bhandari et al., 2001). From 
4 days onwards, HepG2 attached onto microspheres secreted albumin 2-4 times more 
than that on the positive control. However, the proliferation was only 0.8-1.9 times of 
the positive control (Figure 3-7), so the higher level albumin secretion could be 
attributed mainly to the improvement of hepatic function by the cell-scaffold 
aggregation. Compared to HepG2, Hep3B cells expressed much higher levels of 
albumin secretion. After 7 days of culture, Hep3B cells grown on microspheres 
secreted albumin up to 30 times more than that by HepG2 cells. According to the 
results obtained by ELISA, it can be seen that albumin secretion by HepG2 and Hep3B 
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cells were well preserved on microsphere scaffolds and the levels were much higher 
than that on the positive control.  
 
Our experiments indicated that HepG2 cells could not express P-450 functions. 
Therefore only Hep3B cells were used to test this hepatic function. The cytochrome P-
450 enzyme activities of Hep3B grown on the positive control and microsphere 
scaffolds were measured over one week in culture and the results are shown in Figure 
3-9. Although there are no statistically significant differences among the three different 
sizes of microsphere scaffold (p>0.05), the P-450 activities of Hep3B cultured on 
microspheres were significantly higher than the positive control. The higher P-450 
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Figure 3-9. Cytochrome P-450 activity of Hep3B cells cultured on 
positive control (     ), M1 (     ), M2 (     ) and M3 (     ). Values represent 
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control again proved that the aggregation of cells on microspheres can improve hepatic 
cellular functions. Taken together, 3D microsphere scaffolds are proved to be suitable 
substrates to guide liver cell proliferation and function, with a potential role in 
regenerating liver tissue in vitro. 
 
3.3 Conclusions 
In this chapter, polymeric microspheres fabricated from poly(3-hydroxybutyrate-
co-3-hydroxyvalerate) (PHBV, 8% PHV), were explored as novel scaffold for liver 
tissue regeneration. Compared to cells cultured on 2D controls, cells grown on 
microsphere scaffold showed higher proliferation rates as well as improved hepatic 
functions. This could be attributed to the large surface area provided by the 
microspheres, which allowed larger number of cell to grow. More importantly, it is 
believed that the spherical shape of the scaffold affects cell adhesion, proliferation and 
function greatly. Smaller microspheres improved cell-cell interaction and cell-substrate 
interaction which can stimulate cell proliferation and function. It was found that PHBV 
microspheres with the size range between 100-300µm were suitable for supporting the 
growth of the liver cells. Light and SEM images showed that the microspheres were 
assembled by the cells into various shapes after two weeks of culture, which would be 
desirable for the regeneration of irregular shaped defects or complex organs. Although 
multilayers of cells was formed among the cell-scaffold constructs, the viability of the 
cells was well preserved as confirmed by live/dead imaging assay. All of these 
indicated that the PHBV microsphere is a promising scaffold for liver tissue 
regeneration and further investigation should be carried out.  
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Chapter 4 Proteins Combination on PHBV 
Microsphere Scaffold to Regulate Hep3B Cells 





In the previous chapter, PHBV microspheres have been shown to be well suited for 
liver cell growth, judging from the high cell proliferation as well as improved hepatic 
functions. For the successful engineering of liver tissue, the creation of a proper 
biomimetic environment for hepatocytes growth and functionality are equally 
important. Extracellular matrix (ECM) proteins and peptides are believed to be able to 
regulate the attachment, migration and growth of cells by binding to the integrin 
receptors on cellular membranes. Therefore, immobilization of these cell adhesive 
molecules onto the scaffold surface is hypothesized to be a mean of mimicking the in 
vivo environment, and therefore had been widely studied for tissue engineering 
application (Carlisle et al., 2000; Hong et al., 2005; Ku et al, 2005). 
The ECM of hepatocytes in vivo is a dynamic structure having different 
compositions during the different developmental phases of the liver. In fetal 
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developing livers, hepatocytes are surrounded mainly by basement membrane 
components such as laminin while collagen is sparsely distributed. Sinusoidal laminin 
is also present in large amounts in the regenerating liver. This suggests that laminin 
plays a part in the growth stimulation of hepatocytes. On the other hand, during liver 
cirrhosis, collagen type I amounts are relatively increased, which suggests that higher 
collagen levels are inhibitive of cell growth (Clement et al., 1992). Sanchez et al (2000) 
investigated how different ECM proteins affect the morphology, growth and 
differentiation of rat hepatocytes. They found that all of these proteins improved cell 
attachment to a similar extent while cells exhibited cord-like structure and expressed 
higher liver specific genes only when cultured on fibronectin coated petri-dishes. 
However, Mooney believed that instead of the type of ECM proteins, the densities at 
which they were presented to the cells could be the key to switch the hepatocytes from 
differentiation to growth state (Mooney et al., 1992). Similarly, peptide sequences 
derived from these proteins have been commonly studied to replace the functions of 
the whole proteins themselves. However, the synergistic effects of combination ECM 
proteins on polymeric scaffolds have not been widely studied for tissue engineering 
purpose. 
Although the effects of ECM proteins on hepatocytes have not been fully 
characterized, there is sufficient data showing that ECM proteins do affect hepatocyte 
growth and function. In this chapter, we aim to demonstrate the versatility of 
microspheres as tissue engineering scaffold through simple modification of the 
scaffold surfaces in a controllable manner. The surfaces of PHBV microspheres were 
modified with collagen (type I), fibronectin and laminin. These proteins are the major 
ECM components. With the ultimate aim to mimic the in vivo conditions of the body, 
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we have cultured a model liver cell line, Hep3B, either on microspheres grafted with 
single protein type or on mixtures of microspheres individually grafted with one of the 
three proteins. The proliferations and functions of Hep3B cells grown on the mixture 
samples were further compared with the cells grown on microspheres grafted with two 
types of cell adhesive peptides, Arg-Gly-Asp (RGD) and Tyr-Ile-Gly-Ser-Arg 
(YIGSR). The aim of this work is to show that various ECM proteins do interact with 
Hep3B cells in a synergistic manner to regulate cell activity and functionality. 
4.1. Materials and Methods 
4.1.1 Materials 
Collagen (type I), fibronectin and laminin were purchased from BD Biosciences 
(San Jose, CA, USA). Arg-Gly-Asp (RGD), Tyr-Ile-Gly-Ser-Arg (YIGSR), N-Ethyl-
N'-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC), N-
Hydroxysulfosuccinimide sodium salt (Sulfo-NHS), MES buffer (pH=6.0), fluorescein 
isothiocyanate (FITC), hydrogen chloride (HCl) and pluoronic-127 were purchased 
from Sigma-Aldrich (St. Louis, MO, USA). Sodium hydroxide (NaOH) was purchased 
from Merck. Micro BCATM Protein Assay Kit was purchased from Pierce (Rockford, 
USA). AccQ • Tag amino acid analysis kit was purchased from Waters (Milford, USA). 
The information of the chemicals which were used in this chapter but not listed in this 
section can be found at section 3.1.1 in Chapter 3. All chemicals were used directly 
without further purification. 
4.1. 2 Microsphere fabrication and surface hydrolysis 
The PHBV microspheres were fabricated using an established method (rf. 3.1.2 in 
Chapter 3). The PHBV microspheres obtained were separated by using standard sieves 
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to get a diameter of 100-300 µm and used for the following studies. The external 
surface morphologies of the microspheres were characterized by a scanning electron 
microscope (SEM) (JSM-5600VL, JEOL, Tokyo, Japan). 
In order to introduce functional groups, PHBV microspheres were hydrolyzed in 6 
M NaOH solution for 15 min at room temperature with shaking at 130 rpm (Unimax 
1010, Heidolph Instruments, Germany). The NaOH solution was aspirated out and 
replaced with distilled water, followed by shaking for 1 min to wash off residual 
solutes. This washing process was repeated five times. 
4.1.3 Proteins/peptides conjugation on the surface of PHBV microspheres 
The hydrolyzed microspheres were re-suspended into MES buffer (pH=6.0) 
containing 10 mM EDC and 10 mM sulfo-NHS to activate the carboxyl groups on the 
surfaces, and shaken at 130 rpm during the reaction for 6 hours. The surface-activated 
microspheres were washed five times with distilled water to remove the un-reacted 
EDC and sulfo-NHS, and subsequently immersed in PBS buffer (pH=7.4) containing 
0.05 µM proteins or 0.6 mM peptides and shaken at 130 rpm for 24 hr at room 
temperature. The supernatant was aspirated out and the microspheres obtained were 
washed five times. The modified microspheres were then dried in the freeze dryer and 
stored at -20°C freezer. Three sets of microspheres conjugated with different types of 
ECM proteins (Collagen, Laminin or Fibronectin) respectively were obtained through 
this way. The mixtures of these three sets of microspheres in different mass ratios 
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In order to get a qualitative understanding on how the conjugated molecules 
distributed on the surface, proteins and peptides-modified microspheres were dyed 
with FITC which is widely used to attach a fluorescent label to proteins via amine 
group. The labeled microspheres were observed under a confocal laser scanning 
microscope (CLSM, Leica, DM-IRE 2). 
4.1.4 Determination of surface conjugation density 
The protein quantity on the microsphere surface was determined using a Micro 
BCATM Protein Assay Kit according to the manufacturer’s instruction. Briefly, 30 mg 
of each microsphere samples were immersed in 1 mL of ultra-pure water followed by 
the addition of 1 mL of the Micro BCA working solution. The resulting solution was 
incubated at 60°C in a water bath for 1hr. After being cooled to room temperature, the 
developed solution was transferred to a cuvette and the absorbance was measured by a 
spectrophotometer at a wavelength of 562 nm. Blank microspheres were used as the 
control. Triplicate samples were prepared for testing purposes. 
The peptide densities on the modified microspheres surface were measured using 
an AccQ • Tag amino acid analysis kit (Waters) followed by a high performance liquid 
chromatography (HPLC) test. Briefly, 10 mg of peptide-modified microspheres were 
immersed in a glass vial containing 0.5 mL of 6 M HCl and hydrolyzed at 115°C for 
24 hour. After the solution was cooled to room temperature, the vial was dried under 
vacuum. The residual was reconstituted by adding 100 µL of 20 mM HCl, 300 µL of 
AccQ • Tag buffer and derivated with 20 µL of AccQ • Fluor Reagent. The 
concentrations of amino acid derivatives were measured using HPLC (Shimadzu, 
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Japan) with a fluorescence detector. Blank microspheres were used as the control. 
Triplicate samples were prepared for testing purposes. 
4.1.5 Atomic composition of microsphere surface  
The chemical structure and atomic composition of the blank and surface-modified 
microspheres were characterized using X-ray photoelectron spectroscopy (XPS, VG 
ESCALAB 220I-XL, Thermo VG Scientific, UK), with the data processing performed 
using XPSPEAK (Raymond, W.M. Kwok, Hong Kong). Wide scan (0-1000eV) and 
high-resolution (C1s, O1s and N1s) spectra were acquired respectively.  
4.1.6 Cell culture and seeding on microspheres 
Human hepatoma cell line Hep3B cells (ATCC) were cultured in DMEM 
supplemented with 10 v/v% FBS, 110 mg/L sodium pyruvate and 1% antimycotic 
solution. The cells were maintained in T-75 flasks in an incubator at 37ºC in the 
presence of 5% CO2 and 95% relative humidity. The medium was renewed every three 
days. 
Microspheres were sterilized using 70 v/v% ethanol followed by washed with 
sterilized PBS for three times. To prevent cells from attaching to the bottom of the 
wells, a 24-well plate was coated with 1% w/v pluronic-127 (Caldwell, 1997) (Control 
experiments indicated that more than 90% cells were prevented from attaching to the 
bottom of the wells coated with pluronic-127) and a glass ring with 9 mm diameter 
was attached on the center of each well before use. Five milligram of sterilized 
microspheres was transferred to the glass rings in each well to form monolayer, and 
cells were subsequently seeded at 3×104 cells/well. In order to further mimic the in 
vivo environment, individual protein conjugated microspheres were added in the mass 
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ratios of 1:1:1, 3:1:1 and 1:3:3 (Collagen : Fibronectin : Laminin) to form the mixed 
protein conjugated samples. The glass rings were taken out and the plate was topped 
up to 1 mL of DMEM per well after 1.5 hour of incubation.  
4.1.7 Cell morphology and viability 
The morphologies of cells and cell-microsphere constructs were observed under an 
optical microscope and images were taken at different days of culture (rf. 3.1.5 in 
Chapter 3).  
The viability of Hep3B cells cultured on the surface modified microspheres was 
assessed using a live/dead assay (rf. 3.1.5 in Chapter 3). 
Clear and more detail images of cell-microsphere constructs were obtained by 
fixing the cells with 2.5 v/v% glutaraldehyde and observed under SEM (rf. 3.1.5 in 
Chapter 3).  
4.1.8 Cell proliferation and functionality 
The proliferations of the cells grown on surface modified microspheres were 
quantified by using MTT assay. Two liver functions, albumin secretion and 
cytochrome P-450 activity, were quantified by using ELISA and EROD assays. The 
detailed description of these assays can be found at 3.1.6 in Chapter 3.  
4.1.9 Statistical analysis 
All data are presented as mean ± standard deviation. One-way Analysis of 
Variance (ANOVA) followed by Tukey’s Honestly Significant Difference (HSD) post 
hoc analysis were carried out to do the statistical comparison and *p<0.05 was 
considered as significant difference.  
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4.2 Results and Discussion 
4.2.1 Surface coverage of protein-modified microsphere 
The surface modified microspheres which were labeled with FITC were observed 
under confocal laser scanning microscope and the images were shown in Figure 4-1. 
The successful conjugation of protein and peptide molecules was verified by the 
presence of a completely fluorescent green surface of the PHBV microspheres. The 
stronger fluorescence on peptide-conjugated microspheres (Figure 4-1d and 4-1e) 
indicated that larger numbers of peptide molecules were grafted which was consistent 
with the surface density assay (Table 4-1).  The possible reason for this is that the 
RGD and YIGSR molecules were much smaller than proteins molecules which 
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4.2.2 Surface density of conjugated molecules 
The surface densities of conjugated proteins were quantified using micro BCATM 
protein assay and the results were shown in Table 4-1. It was observed that the surface 
density of conjugated collagen was higher than that for laminin and fibronectin. This 
could be due to the larger conformational size of laminin (900,000 Daltons) and 
fibronectin (440,000 Daltons) molecules resulting in greater steric hindrance during 
grafting. It was also believed that self-assembly of fibronectin into fibrils may occur 
during the conjugation process and decrease the amount of fibronectin grafted onto the 
surface (Hynes, 1990).  
Figure 4-1. CLSM images of surface modified PHBV microsphere grafted with (a) 
Collagen, (b) Fibronectin, (c) Laminin, (d) RGD, (e) YIGSR, and (f) SEM image of 
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Table 4-1: Surface density of proteins conjugation to microspheres 
Samples Surface Density (pmol/cm2) 
Collagen 2.193 ±0.355 
Laminin 0.704±0.181 
Fibronectin 0.670 ±0.135 
RGD 36.92±12.68 
YIGSR 16.24±5.21 
* MW of collagen, Lamin and Fibronectin was 300,000, 900,000 and 440,000 Daltons, respectively. 
As explained in the previous section, peptides with shorter chains were conjugated 
to the surface with a much higher densities as compared to proteins due to the lower 
steric hindrance of smaller peptides molecules. 
4.2.3 XPS spectra of modified surface 
X-ray photoelectron spectroscopy analysis was performed to monitor the changes 
of the surface composition during the modification process. The successful 
conjugation of proteins and peptides on microsphere surfaces were verified by the 
presence of nitrogen (N1s) peaks at 398.1 eV from the XPS spectra (Table 4-2). There 
were no nitrogen peaks from the XPS spectra of intact PHBV and NaOH treated 
microspheres. The NaOH-treated surfaces showed a decrease of oxygen concentration. 
However, the decreasing trend does not necessarily mean that the number of hydroxyl 
and carboxyl groups on the surface has been reduced. This is because the XPS probes a 
layer of about 4-7 nm thick (Merrett et al., 2001; Gan et al., 2003), which includes the 
bulk polymer, thus the total peaks from both terminal hydroxyl or carboxyl groups that 
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has been created and ester bonds in the bulk PHBV cannot be distinguished in the XPS 
spectra. Several previous works have proved that carboxyl groups could be introduced 
by NaOH hydrolysis of the ester bond of PGA and PHB films (Yang et al., 2002; Lee 
et al., 2004). Therefore, it can be postulated that the number of carboxyl groups was 
increased by the surface hydrolysis, but the relatively more methyl groups present due 
to the slower degradation of monomer units would have lead to higher peak areas of 
the methyl carbon.  
Table 4-2: Atomic composition and percentage of C1s in XPS spectra of native and 
modified PHBV microspheres 
Atomic Conc. % Peak Ratio (%) of C1s 
samples 









Untreated - 32.54 67.46 50.66 - 28.66 20.68 
NaOH - 27.52 72.48 46.52 - 33.51 19.97 
Collagen 7.22 21.24 71.54 37.66 19.12 31.88 11.34 
Fibronectin 3.95 26.30 69.75 46.33 16.53 21.47 15.66 
Laminin 2.79 24.86 72.35 44.23 13.60 23.97 18.19 
RGD 2.06 22.83 75.11 35.60 19.35 28.87 16.18 
YIGSR 3.18 26.21 70.61 40.66 14.35 25.43 19.56 
 
Figure 4-2 shows the XPS spectra of C1s peaks with the detailed values of peak 
ratios summarized in Table 4-2. The NaOH-treated microspheres showed a decrease in 
the area of peak for C-C, while an increase for hydroxyl carbon, C-O. The increase of 
hydroxyl carbon is related to the oxygen insertion from water by nucleophilic attack of 
water molecules during the hydrolysis process to form carboxyl groups. It can also be 
seen that a new carbon bond, C-N, was introduced for proteins and peptides grafted 
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microspheres (Figure 4-2c to 4-2g). The higher percentages of C-N peak areas were 
consistent with higher nitrogen atomic concentration as indicated in Table 4-2.  
 
Figure 4-2. XPS spectra (C 1s) of 
PHBV microspheres (a) Blank, (b) 
NaOH treated, and surface 
conjugated with (c) RGD, (d) 
YIGSR, (e) Collagen, (f) 
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4.2.4 Morphologies of Hep3B cells grown on surface-modified microspheres 
A human hepatoma cell line Hep3B was used as model liver cells to study the 
effects of the modified microspheres on liver cell proliferation and function. Cells were 
cultured either on single proteins grafted microspheres (Collagen, Laminin, and 
Fibronectin), or on mixtures of microspheres individually grafted with the three types 
of proteins respectively in different mass ratios (Collagen: Laminin: Fibronectin at 
1:1:1, 3:1:1 and 1:3:3). 
4.2.4.1 Optical micrographs 
No significant differences in the morphologies of the Hep3B cells cultured on the 
blank, protein-conjugated and mixed protein-conjugated samples were observed under 
optical microscope [Figure 4-3 (a), (c) and (d)]. Only the cells cultured on NaOH-
treated microspheres showed a different morphology [Figure 4-3 (b)]. Images taken at 
a residence time of one week were used as representatives. It was observed that the 
cells spread and flattened on blank and protein-grafted microspheres, and many 
microsphere-aggregates were virtually encapsulated by the cells and formed a three-
dimensional tissue-like structure (Figure 4-3). Although there were no significant 
differences in the morphology of the Hep3B cells cultured on the blank and protein-
conjugated microspheres, the cells spread more extensively when cultured on protein-
conjugated samples and more microspheres were bridged together to form thicker 
tissues. Studies by others have also indicated that hepatocytes exhibited a flat and 
extended morphology when cultured on ECM proteins coated substrates with certain 
densities (Benzeev et al., 1988; Mooney et al., 1992). It was believed that ECM 
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proteins coated on rigid, planar surfaces could stimulate the gene expression of major 
cytoskeletal proteins through binding to specific integrin receptors and therefore 
regulated the morphology of the cells (Mooney et al., 1992). However, for NaOH 
samples, cells were absent on large portion of the microspheres and many cells that 
remain attached were round in shape (indicated by arrows at Figure 4-3b), which in 
general, could be associated with partial cellular degeneration. These images have 
shown that the surface-modified microspheres were conducive towards the attachments 
and spreading of the Hep3B cells. The morphologies of Hep3B cells grown on 
fibronectin, mixed protein-conjugated samples, RGD and YIGSR grafted microspheres 
were similar to the cells grown on collagen-grafted microspheres (images not shown).  
 
Figure 4-3. Optical microscope images of cell-microsphere constructs cultured 
for one week on (a) Blank, (b) NaOH treated, (c) Collagen-conjugated, and (d) 
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4.2.4.2 Confocal laser scanning micrographs  
The cells were stained with a live/dead kit (Molecular Probes) to examine their 
viability grown on surface modified microsphere scaffold. The fluorescent green-
colored indicated live cells while the fluorescent red-colored were dead cells. CLSM 
images proved that most of the cells grown on blank and treated microspheres were 
viable. Cells were found to be better distributed on protein-conjugated microspheres 
[Figure 4-4(c) and (d)] as compared to the blank and NaOH-treated microspheres 
[Figure 4-4 (a) and (b)], which indicated that the immobilization of these bioactive 
molecules improved the biocompatibility of PHBV microspheres.  
  
Figure 4-4. CLSM images of cell-microsphere constructs cultured for one 
week on (a) Blank, (b) NaOH treated, (c) Collagen-conjugated, and (d) 




150 μm 150 μm
100 μm 100 μm
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4.2.4.3 Scanning electron micrographs  
SEM images of Hep3B c ells after one week of culture on blank and surface 
modified PHBV microspheres are shown in Figure 4-5. It was observed that the cells 
had encapsulated the microspheres and aggregated them into 3D clumps. This 
suggested that the microspheres were good substrates for Hep3B cells, and thus also 
hepatocytes, to grow on by allowing extensive cell-cell and cell-substrate interactions 
to occur. Similar to optical and confocal micrographs (Figure 4-3 and Figure 4-4), cells 
were found to be better distributed on protein-conjugated microspheres as compared to 
the blank and NaOH-treated microspheres. The cells covered the whole surfaces of the 
microspheres and strong cell-substrate interactions were found on protein-conjugated 
samples [Figure 4-5 (d)].  
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4.2.5 Proliferation activity of Hep3B cells grown on microsphere scaffold 
The proliferation activities of Hep3B cells grown on the blank as well as on the 
surface modified microspheres were quantitatively evaluated by MTT assay during the 
two weeks of culture (Figure 4-6). As shown in Figure 4-6 (a), the cells cultured on 
single protein conjugated microspheres showed no significant improvements of 
proliferation over the blank after two days of culture. A study by Tomomura indicated 
that different types of ECM protein coated substrates have no significant effects on the 
DNA synthesis of liver cells in 24 hr to 48 hr as the cells were in the lag growth phase 
Figure 4-5. SEM images of cell-microsphere constructs cultured for one week on (a) 
Blank, (b) NaOH treated, (c) Collagen-conjugated PHBV microspheres; (d) higher
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(Tomomura et al., 1987). From day 4 onwards, the cells showed improved proliferation 
activities when cultured on protein conjugated microspheres, especially on laminin 
conjugated sample over the blank, while no significance differences were found among 
the three protein conjugated samples [Figure 4-6 (a)]. According to Mooney, high 
ECM density activated hepatocytes spreading and proliferation, regardless of the type 
of ECM molecules used. Since the surface densities of the three proteins on the 
microspheres were in the range of 200-600 ng/cm2, it was believed that the cells had 
been stimulated into the S phase with higher proliferation activities (Mooney et al., 
1992). Studies by others suggested that growth and gene expression of hepatocytes 
were dependent on the interactions of cells with different ECM substrates, however 
these effects were absent at high cell density (Bissell et al., 1987; Tomomura et al., 
1987). Taken together, the three types of proteins might be different in terms of 
improving cell proliferation but the differences could have been diminished by the 
naturally high proliferation rate of the Hep3B cell line and strong cell-cell interactions 
induced by the tissue-like constructs.  
Compared to the other samples, the cells cultured on NaOH sample exhibited the 
lowest proliferation rate, which was consistent with what was observed using the 
optical microscope (Figure 4-3). The reduced proliferation activity could probably be 
attributed to the more hydrophilic surface formed by the surface hydrolysis process 
using NaOH, which introduced carboxyl and hydroxyl groups to the surface. It has 
been reported that cells would have the maximum adhesion on surfaces with an 
intermediate hydrophilicity (Saltzman, 2000). In this regard, a more hydrophilic 
surface may inhibit cell attachment. Furthermore, the significant improvement of 
overall protein-conjugated samples as compared to the NaOH samples indicated that 
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the conjugation process was successful in making the microspheres more conducive to 
cell proliferation.  
In an attempt to develop an improved liver tissue engineering system, we 
hypothesized that culturing Hep3B cells onto microsphere scaffolds with combinations 
of different ECM proteins on the surface would improve cell proliferation activity and 
functionality. From the MTT results [Figure 4-6 (b)], it is interesting to note that the 
mixed protein-conjugated samples produced a significant improvement in proliferation 
of Hep3B cells. It can be observed that mixtures of 1:1:1, 3:1:1 and 1:3:3 (Collagen: 
Laminin: Fibronectin) microspheres showed an average of 1.4 times greater cell 
proliferation activity than collagen conjugated microspheres and around 1.6 times 
greater than the blank from day 7 onwards. The three types of ECM molecules used in 
this work contain distinct peptide sequences which can bind with different integrin 
receptors on the membranes of hepatocytes. When microspheres conjugated with 
different proteins were bridged together (Figure 4-3 to Figure 4-5), the Hep3B cells 
would have chances to interact with different proteins through multiple ECM receptors. 
These interactions might function to re-organize the cytoskeletons of the cells, which 
were associated with the regulation of gene expression and DNA synthesis. Studies by 
others showed that the response of hepatocytes cultured on a complex substratum 
(EHS gel, an ECM derived from EHS tumor) were strikingly different from that on 
individual matrix proteins like type I collagen gel (Bissell et al., 1987; Benzeev et al., 
1988). The results presented here were consistent with these findings in term of the 
synergistic effects of various proteins, but our results also demonstrated that the 
combination of proteins on rigid polymer surface could improve the cell extension as 
well as stimulate cell proliferation activity. 
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Figure 4-6. Proliferation of Hep3B cells cultured on (a) Blank (    ), NaOH treated 
(    ), Collagen-conjugated (    ), Fibronectin-conjugated (    ), Laminin-conjugated 
(   ); and (b) proteins combination (Collagen:Fibronectin:Laminin) with a ratio as 
1:1:1 (   ), 3:1:1 (   ), and 1:3:3 (   ) PHBV microspheres.  Values represent 
means±SD, n=3. Statistical significance (*p<0.05) was determined by one-way 
ANOVA with Tukey’s HSD post hoc analysis. 
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4.2.6 Albumin secretion by Hep3B cells grown on microsphere scaffold 
Albumin secretion is an important indicator of hepatic function for normal primary 
hepatocytes, and can be similarly modeled by the Hep3B cells. In general, there was a 
trend of increasing albumin secretion with time elapsed for all samples (Figure 4-7). 
This was expected as it was known from the MTT data that cell proliferation activity 
increased and thus, the greater number of living cells present would have secreted 
more albumins. It is interesting to note that the cells cultured on mixed protein-
conjugated microspheres did not show improved albumin secretion ability although 
they had a much higher proliferation rates, which indicated that the synergistic effect 
of combination ECM proteins on rigid polymer surface functioned more for improving 
cell proliferation. On the other hand, the blank samples showed higher albumin 
secretion over most of the other samples while they showed lower proliferation rates. 
As discussed in section 4.2.5, the high surface densities of proteins may have 
stimulated the higher percentage of cells into S phase with a concomitant down-
regulation of differentiated functions. Our results are consistent with the findings by 
others that hepatocytes could be switched from differentiation to proliferation cycle 
through binding with different ECM molecules (Mooney et al., 1992; Rana et al., 1994; 
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Figure 4-7. Albumin secretion by Hep3B cells cultured on (a) Blank (    ), NaOH 
treated (   ), Collagen-conjugated (   ), Fibronectin-conjugated (   ), Laminin-
conjugated (    ); and (b) proteins combination (Collagen:Fibronectin:Laminin) with a 
ratio as 1:1:1 (    ), 3:1:1 (    ), and 1:3:3 (    ) PHBV microspheres. Values represent 
means±SD, n=3. Statistical significance (*p<0.05) was determined by one-way 
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Albumin secretion by the cells cultured on the NaOH samples was significantly 
lower than other samples. This is very likely to be caused by a low population of cells 
present, as indicated by the poor proliferation shown in the MTT results. However, the 
difference is not proportional to the proliferation results. For example, by the last day 
of culture, the sample with the highest proliferation (mixture sample, collagen: laminin: 
fibronectin=1:3:3) was around 3 times of NaOH samples, while albumin secretion for 
this case was only around 1.2 times. There are two possible explanations. Firstly, the 
spherical shape of cells grown on NaOH samples [Figure 4-3 (b)] may suggest partial 
cellular degeneration which resulted in the release of intracellular albumin into the 
medium. Secondly, the rounded cell shape may also suggest elevated differentiated 
hepatic functions (Bhadriraju and Hansen, 2000). The study by Mooney indicated that 
low density proteins did not promote cell spreading, and the cells that remained 
spherical expressed higher liver specific functions (Mooney et al., 1992). 
4.2.7 P-450 activity of Hep3B cells grown on microsphere scaffold 
Another important indicator of liver hepatocyte function that can be modeled by 
Hep3B cells is the cytochrome P-450 enzyme activity. The P-450 activities of Hep3B 
cells grown on microsphere scaffolds are shown in Figure 4-8, which indicated the 
detoxification ability of Hep3B cells over 3 hours at the test day. Similar to the ELISA 
results, the blank samples had higher P-450 activity over most of the other samples, 
which suggested that cells with lower proliferation rate may have higher differentiated 
functions. As explained above, combination of proteins did not show a conclusive 
enhancement to the P-450 activity. By the last day of culture, the P-450 activity of 
samples with the highest proliferation rate (3 times more than that of NaOH samples) 
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was only around 1.5 times more than that of NaOH samples. Since decomposed cells 
could not perform P-450 activity, this interesting result suggested that Hep3B with 
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Figure 4-8. Cytochrome P-450 activity of Hep3B cells cultured on (a) Blank (   ), 
NaOH treated (   ), Collagen-conjugated (   ), Fibronectin-conjugated (   ), Laminin -
conjugated (   ); and (b) proteins combination (Collagen:Fibronectin:Laminin) with a 
ratio as 1:1:1 (   ), 3:1:1 (   ), and 1:3:3 (   ) PHBV microspheres. Values represent 
means±SD, n=3. Statistical significance (*p<0.05) was determined by one-way 
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4.2.8 Hep3B cells grown on peptide-grafted microsphere scaffold 
We have demonstrated that the conjugation of ECM proteins on the microsphere 
surfaces was an effective way to improve the biocompatibility of the scaffold. It was 
also reported that the integrin receptors on the cell membranes bind to specific 
sequences in the ECM proteins, which are called cell adhesive peptides. Compared 
with the whole protein, short cell adhesive peptides can be coupled in high densities 
onto the scaffold surfaces (rf. Table 4-1), and are available at a lower cost. In order to 
further investigate the synergistic effects of the ECM proteins, the proliferation and P-
450 activity of Hep3B cells grown on the proteins mixture samples were compared 
with the cells grown on microspheres conjugated with two types of cell adhesive 
peptides, RGD and YIGSR. 
The proliferation of Hep3B cells grown on blank, peptide-conjugated microspheres 
and the proteins mixture sample were quantitatively evaluated by MTT assay during 
the two weeks of culture. For convenient comparison, the absorbance of MTT solution 
from blank microsphere at day 2 was set as a benchmark. The ratios of absorbance of 
MTT solution from other samples to the benchmark were used to evaluate cell 
proliferation on the corresponding substrates as shown in Figure 4-9. As expected, the 
mean proliferation rates of the Hep3B cells grown on peptides conjugated samples 
were higher than the blank samples from day 7 onwards. It was also slightly higher 
than the single protein conjugated samples (rf. Figure 4-6). This could be attributed to 
the higher densities of the peptides onto the scaffold surface which improved the cell 
attachment as well as DNA synthesis. However, the cells grown on the proteins 
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mixture samples showed much higher proliferation rate than the cells grown on peptide 
conjugated samples. This further validated our previous finding that the combination 
of three ECM proteins produced a synergistic effect on all of the cell surface receptors 

























The P-450 activities of Hep3B cells grown on blank, peptide-conjugated 
microspheres and the proteins mixture sample are shown in Figure 4-10, with the P-
450 activity at day 2 of the blank microspheres as the benchmark. In general, there was 
a trend of increasing P-450 activity with time for all samples, which could be 
Figure 4-9. Proliferation of Hep3B cells cultured on Blank (   ), RGD-
conjugated (  ), YIGSR-conjugated (  ); and proteins combination 
(Collagen:Fibronectin:Laminin) with a ratio as 1:1:1 ( ) PHBV 
microspheres. Values represent means±SD, n=3. All data were normalized to 
the ratios of blank microsphere at day 2, which was taken as a benchmark. 
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attributed to the increased cell numbers. The cells grown on blank microspheres 
showed higher P-450 activity over the surface modified samples, and there were no 
significant difference between the cells grown on peptides conjugated microspheres 
and the proteins mixture samples. As discussed in section 4.2.6, the surface 
modification functioned more on improving cell proliferation rather than the 
differentiated functions. The results for albumin secretion by Hep3B cells showed 






















Figure 4-10. Cytochrome P-450 activity of Hep3B cells cultured on Blank 
(     ), RGD-conjugated (    ), YIGSR-conjugated (    ); and proteins combination 
(Collagen:Fibronectin:Laminin) with a ratio as 1:1:1 (    ) PHBV microspheres. 
Values represent means±SD, n=3. All data were normalized to the ratios of 
blank microsphere at day 2, which was taken as a benchmark. 
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4.3 Conclusions 
In this chapter, the viability of using PHBV microspheres as tissue engineering 
scaffolds was improved through controlled surface conjugation with extracellular 
matrix (ECM) proteins, namely collagen, laminin and fibronectin. Successful 
conjugations of protein molecules were verified by the presence of nitrogen peaks in 
X-ray photoelectron spectroscopy and fluorescent green surface of microspheres in 
fluorescence microscopy. The improved proliferation of cells cultured on mixtures of 
the three types of protein-conjugated microspheres suggested that the proliferation 
activity of Hep3B did not just depend on single protein, but involved complex 
interactions between the three ECM components. Therefore, combinations of ECM 
components is important not just in improving the biocompatibility of tissue 
engineering scaffolds, but also in enhancing cellular function. Furthermore, 
hepatocytes with round morphology were found to perform better hepatic functions 
while having lower proliferation. Conversely, high proliferation would tend to lower 
cell function. Thus, in the design of a tissue engineering system, a scaffold showing 
different surface properties at different cell development stages might be necessary. 
The results in this chapter indicated that surface conjugation of the three ECM proteins 
on microsphere surfaces has a significant effect in regulating the behavior of Hep3B 
cells, thus better mimicking the in vivo environment for liver tissue engineering. 
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Chapter 5 Delivery of Hepatocyte Growth 






The previous two chapters have demonstrated that polymer microspheres with 
reproducible three-dimensional structures and easily modified surfaces are promising 
and versatile scaffolds for guiding liver cell growth. In addition to the scaffolds, 
growth factors also play an essential role in promoting cell proliferation and 
differentiation, as well as inducing vascularization (Babensee et al., 2000; Tabata, 
2000; Chen and Mooney, 2003). Therefore, it would be advantageous if a scaffold that 
functions as a substrate for cell attachment, could simultaneously deliver suitable 
growth factors in a controlled manner to stimulate cell growth and new vessel 
formation within the implantation sites (Saltzman, 2002). However, it is not always 
possible to encapsulate growth factors directly into scaffolds due to the complex 
structures and fabrication process. In this regard, use of microspheres is advantageous 
since the growth factors can be encapsulated into microsphere with controllable 
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delivery profiles using well-developed techniques (Cao and Shoichet, 1999; Oe et al., 
2003). 
In this chapter, the encapsulation of hepatocyte growth factor (HGF) into the 
microspheres and subsequent control-release of the growth factors were investigated to 
further improve the microsphere scaffold system. HGF, also called scatter factor, is a 
multiple-function molecule which can interact with various types of cells as well as 
induce angiogenesis when administered with basic fibroblast growth factor (bFGF) 
(Marui et al., 2005). More interestingly, HGF is believed to improve the proliferation 
of primary hepatocytes but inhibit the growth of hepatoma cells. This could be used to 
test its bioactivity (Shiota et al., 1992; Fukai et al., 2003; Oe et al., 2003).  
Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) showed excellent 
biocompatibility to Hep3B and HepG2 cells in previous works. However, PHBV may 
not be a good candidate for encapsulating proteins such as growth factors since most 
proteins are hydrophilic while PHBV is quite hydrophobic due to its high crystallinity. 
Poly(lactic-co-glycolic acid) (PLGA) which also shows good biocompatibility, has 
been shown to be able to encapsulate proteins at higher encapsulation efficiency. In 
order to preserve the excellent biocompatibility of PHBV, while improving its 
encapsulation ability of growth factors, PHBV was mixed with PLGA, and 
investigated as scaffold material for the encapsulation of bovine serum albumin (BSA) 
and hepatocyte growth factor (HGF). Comparison was made with pure PHBV and pure 
PLGA microspheres. The release of BSA served as the model for HGF since both 
proteins have similar molecular weights and hydrophilicity, and the co-encapsulation 
of BSA with HGF is believed to preserve the bioactivity of the growth factor by 
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reducing its exposure to organic solvents. The effects of polymers on the morphologies, 
protein-releases and degradation profiles of the microsphere scaffolds were studied by 
varying the polymer compositions (PHBV, PLGA and PLGA/PHBV). The bioactivity 
of released HGF was assessed by Hep3B cell inhibition assay. Furthermore, primary 
hepatocytes from rats were cultured on the PLGA/PHBV microsphere scaffold for up 
to 10 days to study the effect of directly delivering the growth factors to the cells.  
5.1. Materials and Methods 
5.1.1 Materials 
Poly(lactide-co-glycolide) acid (PLGA, 5050DL 4A) was purchase from 
Lakeshore Biomaterials (Birmingham, AL, USA), PLGA. Recombinant hepatocyte 
growth factor (HGF) was from RayBiotech (Norcross, GA, USA). Hepatocyte growth 
factor detection ELISA kits was purchased from R&D system Inc (Minneapolis, MN, 
USA). Penicillin, dexamethasome and acetone were purchased from Sigma-Aldrich (St. 
Louis, MO, USA). Information of the chemicals which were used in this chapter but 
not listed in this section can be found in section 3.1.1 in Chapter 3. All chemicals were 
used directly without further purification. 
5.1.2 Fabrication of protein-encapsulated microspheres 
A water-in-oil-in-water (w/o/w) emulsion solvent evaporation technique was used 
to fabricate microsphere scaffolds as well as to encapsulate the proteins. Briefly, 500 
mg of PHBV (8%) powder was dissolved in 12 mL of chloroform, and 0.5 mL of 50 
mg/ml BSA (for a protein loading of 5%) phosphate-buffered saline (PBS, 0.01M, 
pH=7.4) solution was added. Emulsification was subsequently carried out by 
Chapter 5 
 
91                        
   
 
sonication in an ice bath using a probe sonicator (VCX130, SONICS & Materials, CT, 
USA) at 50% power output for 40s. The homogenized mixture was immediately added 
into 150 mL of PBS (0.01M, pH=7.4) with 0.05% w/v PVA drop by drop under 
continuous mechanical stirring (RW20, Ika Labortechnik, Staufen, Germany) at 300 
rpm for 4 hours to evaporate the organic solvent. The microspheres produced were 
washed five times with deionized water to remove as much of the surfactant (PVA) 
and BSA attached on the surface as possible and freeze dried in a freeze dryer (Alpha 
1-4, Martin Christ, GmbH, Germany). PLGA and a blend of PHBV/PLGA (1:1, w/w) 
microspheres were prepared using the same methodology.  
Ten micrograms of HGF was co-encapsulated with BSA in PHBV/PLGA 
microspheres as described above, using the same BSA loading of 5% w/w. The co-
encapsulated BSA might serve to protect HGF through reducing the exposure of the 
molecules to shear stress and organic solvent during encapsulation as well as to 
function as a stabilizing agent to prolong the bioactivity of HGF (Cao and Shoichet, 
1992). The release of BSA can also serve as a model for HGF release from the 
microsphere scaffolds and encapsulation efficiency (EE) can be used to estimate the 
EE of HGF. 
5.1.3 Characterization of protein-encapsulated microspheres 
The size distributions of all the three types of microspheres were measured by a 
particle size analyzer (Coulter LS-230, FL, USA). Tween®80 was used to disperse 
microspheres into the water homogeneously. Microspheres were sectioned with a 
cryostat microtome (Leica CM3050S, Germany) with blade step setting at 30 µm and 
air dried. The intact and cross-sectioned microspheres were mounted onto brass stubs 
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using double-sided adhesive tape and vacuum-coated with platinum using the Auto 
Fine Coater (JFC-1300, JEOL, Tokyo, Japan) for 40 seconds. The external and internal 
morphologies were then characterized by a scanning electron microscope (SEM) 
(JSM-5600VL, JEOL, Tokyo, Japan). The surface atomic compositions of the three 
types of microspheres were characterized using an X-ray photoelectron spectroscopy 
(XPS, VGESCALAB 220I-XL, Thermo VG Scientific, UK) with data processing 
performed using XPSPEAK (Raymond, W.M. Kwok, Hong Kong). Wide scan (0-
1000eV) and high resolution (C1s, O1s and N1s) spectra were acquired respectively.   
5.1.4 In vitro degradation of microspheres  
Thirty milligrams of microspheres (PHBV, PLGA or PHBV/PLGA) were 
suspended in an Eppendorf microtube with 1.5 mL of PBS (0.01M, pH=7.4) at 37°C in 
a circulating water bath (100 rpm), and PBS (0.01M, pH=7.4) was changed every 5 
days. At scheduled time, the microspheres were washed with deionized water and 
freeze-dried for 48 hours. The degradation profiles of the microspheres were 
characterized by mass loss using a microbalance (Sartorius MC5, Germany). The 
degraded microspheres were also characterized under SEM to check morphology 
change.  
5.1.5 Encapsulation efficiency assays 
BSA: To determine the encapsulation efficiency of BSA in the microspheres, 20 
mg of microspheres were dissolved in 2 mL of chloroform to which 5 mL of PBS 
(0.01M, pH=7.4) was added. The solution was mixed thoroughly using a vortex mixer 
to extract BSA to the water phase and centrifuged (20 min at 9,000 rpm) to accelerate 
phase separation. The supernatant was aspired out and kept in a 50 mL tube. This 
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process was repeated three times, and the concentration of BSA was measured using a 
Micro BCATM Protein Assay Kit (Pierce). The encapsulation efficiency was calculated 
as the ratio of the actual to the theoretical BSA loadings.  
HGF: Due to the limitations of the assay detection limit (0.5 µg/mL), the Micro 
BCATM assay is not suitable to measure the EE of HGF. Enzyme-linked 
immunosorbent assay (ELISA), which is based on antibody-antigen mechanism, is 
normally used to detect the proteins with very low concentrations. However, the 
extraction process mentioned above could denature the growth factor according to our 
preliminary experiments, making ELISA not a feasible method to measure the EE. 
Therefore, two alternative methods were used to estimate the EE of the HGF: (1) 
Using the EE of BSA as an indicator to estimate the EE of HGF; and (2) Using the 
cumulative release of HGF up to three months as the actual HGF loading in the 
microspheres.  
5.1.6 In vitro release studies 
BSA: Twenty milligrams of each type of BSA-encapsulated microspheres were 
suspended in 1 mL of PBS (0.01 M, pH=7.4) and incubated at 37°C in a circulating 
water bath (100 rpm). At set time points, the microspheres were centrifuged (5 min at 
13, 000 rpm), and the supernatant was collected and stored in a -20°C freezer while the 
microspheres were re-suspended in 1 mL fresh PBS (0.01 M, pH=7.4). BSA content in 
the supernatant was analyzed using HPLC (HP1100, Agilent, USA). A size exclusion 
column for was used as the analytical column (PL Aquagel-OH Mixed, 300mm, 
Agilent, USA). The mobile phase was PBS (0.01M, pH=7.4) and the flow rate was 1.0 
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mL/min. The wavelength of UV detector was set as 210 nm and the sample injection 
volume was 50 µL.  
HGF: For HGF and BSA co-encapsulated microspheres (PHBV/PLGA), 80 mg of 
microspheres were suspended in 8 mL of serum-free medium and incubated at 37°C. 
At set time, the microspheres were centrifuged (5 min at 13, 000 rpm), the supernatant 
was filter-sterilized with a 0.22 µm filter and stored in a -20°C freezer prior to 
concentration and bioactivity analysis. The HGF content in the supernatant was 
analyzed using an ELISA (Hepatocyte growth factor quantification, R&D System, 
USA) kit for hepatocyte growth factor. 
5.1.7 Bioactivity assays for the released proteins 
Hepatoma cell line Hep3B (ATCC) were cultured in a serum-medium which was 
composed of DMEM supplemented with 10% v/v FBS, 110 mg/L sodium pyruvate 
and 1% v/v antimycotic solution (100 units/ml penicillin G, 100 μg/ml streptomycin 
sulfate, and 0.25 μg/ml amphotericin B). The serum-free (SF) medium was defined the 
same as the above mentioned serum-medium except FBS was not added. The cells 
were maintained in T-75 flasks in an incubator at 37ºC in the presence of 5% CO2 and 
95% relative humidity. The medium was renewed every three days. 
The bioactivity of HGF released from PHBV/PLGA microspheres was assessed 
using Hep3B cell proliferation inhibition assays (Shiota et al., 1992). Hep3B cells were 
seeded into a 24-well plate with a concentration of 15,000 cells per well in serum-
medium. After being incubated for 4 hours, the medium was aspired out carefully and 
replaced with 0.5 mL of the released medium from HGF or BSA loaded microspheres. 
SF medium and SF medium supplemented with 5 ng/mL and 50 ng/mL HGF were 
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used as the controls. After the cells were cultured for 24 hours, total DNA 
quantification assay was used to measure the cell proliferation, while enzyme-linked 
immunosorbent (ELISA) and EROD assays were used to determine the functionalities 
of the liver cells.  The detailed description of these three assays (total-DNA, ELISA 
and EROD) can be found at 3.1.6 in Chapter 3. 
The degradation products from the polymer may affect the proliferation and 
function of the cells, and the metabolic activities of the cells may also contribute to the 
degradation of the polymers. In order to determine these effects, 5 mg of PLGA/PHBV 
microspheres was put into a 0.22 µm Transwell Insert (Nunc, Denmark). The inserts 
was then placed in a 24-well plate which has been seeded with Hep3B (15,000 cells 
per well). The cells seeded on the well without the insert was used as a control. At 
scheduled time points, the proliferation and albumin secretion of the cells and the 
degradation of the microspheres were quantitatively measured.  
5.1.8 Culturing primary hepatocytes on PLGA/PHBV microsphere scaffold 
Primary hepatocytes from rats were obtained from an established liver perfusion 
method (courtesy of Department of Physiology, National University of Singapore). 
The culture medium was composed of DMEM supplemented with 10% v/v FBS, 0.1% 
v/v bovine serum albumin, 100 units/mL penicillin, 5 µg/mL insulin and 100 nM 
dexamethasome.  
Primary hepatocytes were seeded on the PHBV/PLGA microsphere using previous 
established method. 3×104 cells were seeded on every five milligram of microspheres 
in a 24-well tissue culture plate. Microspheres without growth factors and blank wells 
were used as controls. To compare the effects of freely administered growth factors to 
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the cells, cell culture medium supplemented with 50 ng/mL of HGF was used as a third 
control to culture the cells grown on the wells.  At set time points, cell proliferation 
and functions were quantified with total-DNA, ELISA and EROD assays (rf. 5.1.7). 
The microspheres and plates were coated with collagen (type IV) before the 
experiments.  
5.1.9 Statistics 
All data are presented as mean ± standard deviation and were analyzed by a one-
way ANOVA followed by Tukey’s HSD post hoc analysis, where the “*” (p<0.05) 
indicate significant difference of the samples to the positive control (serum free 
medium). Student’s t-test were also carried out for statistical comparisons between 
pairs of samples, where the “+” indicate significant difference (p<0.05).  
5.2 Results and Discussion 
5.2.1 Characterization of the microspheres 
The size distributions of the three types of microspheres (PHBV, PLGA and 
PHBV/PLGA) were quantified using Coulter LS-230 and the results were shown in 
Table 5-1. It can be seen that PHBV microspheres have the largest mean diameter 
(210.3 µm), while the mean diameter of PLGA microspheres is the smallest (156.8 
µm). Given that all of the preparation parameters were held constant, this can be 
attributed to the different molecular weights of PHBV and PLGA which are 575.9 kDa 
and 61.6 kDa respectively. The longer carbon chains of PHBV could produce a larger 
microsphere when the polymers entangled together by the force of the surfactant 
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micelles during the emulsion process. Meanwhile the small standard deviations also 
indicate narrow distributions of all the microspheres.  
Table 5-1. PHBV, PLGA and PHBV/PLGA microspheres encapsulated with BSA 
 







PHBV 210.3 ± 35.2 32.52 ± 2.31 59.67 
PHBV/PLGA 185.2 ± 22.5 92.36 ± 3.52 17.66 
PLGA 156.8 ± 23.6 
5 
88.65 ± 1.65 1.12 
* BSA released during the first 24 hour. 
 
The external and internal morphologies of the microspheres were further 
characterized using SEM. As shown in Figure 5-1, all the three types of microspheres 
have spherical shapes, but quite different surface morphologies and internal structures. 
PLGA microspheres have a smooth surface whereas PHBV and PHBV/PLGA 
microspheres have a rough topography with nano-scale pores which can accelerate the 
release of proteins from the microspheres. As indicated in Figure 5-1 (A2), PHBV 
microspheres possess highly porous internal structure with a pore size around 15 µm 
which could be attributed to the high hydrophobic property of PHBV (water contact 
angle of PHBV film is around 79º). During the 1st emulsification process, water 
droplets could not mix with the hydrophobic PHBV molecules homogeneously, 
instead the droplets would coalesce to form bigger droplets among the organic phase, 
and pores found both internally and on the surface [Figure 5-1 (A3)] were formed by 
the removal of the water droplets through lyophilization. Compared with PHBV, 
PLGA molecules are relative more hydrophilic (water contact angle of PLGA is about 
60º), therefore the water droplets could be distributed evenly among the polymer 
solution which resulted in a uniform internal structure [Figure 5-1 (D2)]. 
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 It is interesting to note that the composite PHBV/PLGA microspheres show a 
core-shell structure, a porous core surrounded by a relative dense shell [Figure 5-1 
(B2)]. According to Mathiowitz and colleagues, during the evaporation of the solvent, 
a two-polymer solution tends to phase separate to achieve the most stable 
Figure 5-1. SEM images of PHBV (A), PHBV/PLGA (B), partially dissolved 
PHBV/PLGA (C), and PLGA (D) microspheres, where panels labeled with 1, 2 and 3 
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thermodynamic configuration (Pekarek et al., 1994). The final configuration was 
affected by the preparation variables, such as the solution concentration, weight ratio 
and volume ratio of the two polymers, temperature and solvents used (Leach et al., 
1999; Yang et al., 2003). In order to determine the distribution of the two polymers 
within the blend, the PHBV/PLGA microspheres were suspended in acetone for 3 
hours followed by washing with deionized water, freeze dried and then observed under 
SEM. As shown in Figure 5-1 (C2), the cores of the composite microspheres were 
totally dissolved resulting in a hollow structure. Since PHBV does not dissolve in 
acetone, the results suggest that the core is mainly PLGA by composition. However, as 
compared with [Figure 5-1 (B3)], the shell is also partially dissolved forming a porous 
and rough surface [Figure 5-1 (C3)] which implies that the shell is actually a blend of 
the two polymers. This was further confirmed by analysis for surface chemical 
compositions of the microspheres using XPS (Table 5-2).  
 
Atomic concentration % Microsphere 
C 1s O 1s N 1s 
C/O 
PHBV 70.32 29.13 0.55 2.41 
PHBV/PLGA 68.65 30.62 0.73 2.24 
PLGA 66.68 33.12 0.20 2.01 
PHBV/PLGA* 69.74 29.85 0.41 2.34 
      *After partially dissolved in acetone 
 
Our previous work indicated that either PLGA or PLLA can be located at the core 
or shell in double-walled microspheres, depending on their respective mass ratio.  
Specifically, PLGA and PLLA were found to form the shell and core, respectively for 
mass ratios of PLGA:PLLA > 1:1. In contrast, when PLGA:PLLA is reduced to below 
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1:1, a phase inversion was observed where the more hydrophobic PLLA was located as 
the shell to form double-walled microspheres (Tan et al., 2005). Our current findings 
agree well with the low mass ratio cases mentioned above since the more hydrophilic 
PLGA occupied the core surrounded by the blended shell of PHBV and PLGA. Given 
the similar preparation parameters and methods, this can be explained by the different 
molecular weights. In the present system, the molecular weight of PHBV (575.9 kDa) 
is significantly greater than PLGA (61.6 kDa).  Therefore, besides the mass ratio and 
hydrophilicity, the molecular weight differences of the two polymers are also an 
important factor that can affect the final polymer distribution or configuration.  
5.2.2 Encapsulation efficiency 
The actual protein encapsulated in each type of the polymer microspheres was 
determined quantitatively by an extraction method. As shown in Table 5-1, the 
encapsulation efficiency of PHBV microsphere is very low, only 32.52% of BSA has 
been encapsulated, while PLGA microsphere shows a much higher EE (88.65%). As 
commonly seen in the double emulsion method for the encapsulation of proteins, EE is 
highly dependent on the chemical structure, molecular weight and hydrophobicity of 
the polymers (Cao and Shoichet, 1999). In the present system, hydrophobic PHBV 
may not be fully compatible with BSA to form a stable emulsion due to the significant 
difference in hydrophobicity. It can be seen that the EE of composite PHBV/PLGA 
microsphere is similar to the pure PLGA microspheres although the mass of PLGA is 
only half of that.  As confirmed earlier in section 5.2.1, the PHBV/PLGA microsphere 
has a core-shell structure. The large PHBV molecules distributed within the shell is 
hypothesized to prevent the loss of proteins during the fabrication and washing process. 
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As shown in Table 5-3, HGF was also encapsulated in the composite PHBV/PLGA 
microspheres with a high efficiency. Since the ELISA assay is based on an antibody-
antigen interaction, denatured proteins may not be recognized by the antibodies coated 
on the plates. Therefore, two methods were used to estimate the EE of HGF (Table 5-3) 
in this study. The loading of HGF could be quantified accurately by labeling HGF with 
radioisotope or fluorescent molecules.  
 
 





5  (BSA) 90.88 ± 2.76* 
PHBV/PLGA 180.6 ± 25.6 
0.002  (HGF) 88.62 ± 3.36** 
* Estimated from co-encapsulated BSA 
** Calculated from cumulative release of HGF 
 
 
5.2.3 Degradation of the microspheres 
The degradation of the microspheres encapsulated with BSA was characterized 
with mass loss and SEM. As shown in Figure 5-2, the degradation of PHBV 
microspheres was very slow, only around 7% of initial mass was lost after 110 days. 
The slow rate can be attributed to the high crystallinity of PHBV resulting from its 
repeat units with a short methyl side group. In contrast, PLGA microspheres showed a 
faster mass loss between 14 and 50 day as indicated by a steep slope, and the 
microspheres degraded completely after two months. The hydrolysis of ester bonds in 
the PLGA backbone generated carboxylic acids which can further catalyze the 
Table 5-3. PHBV/PLGA microspheres with BSA and HGF co-encapsulated 
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degradation (autocatalytic hydrolytic degradation) and resulted in the accelerated 
degradation of PLGA microspheres. Since both PHBV and PLGA are polyesters, their 
degradation by-products are small molecule acids which are not harmful to the cells. 
This was verified when Hep3B cells were cultured in the presence of the degradation 
products of PHBV and PLGA, and no significant differences were observed in the 
proliferation and albumin secretion of the cells (section 5.1.7, data not shown). 
However, for in vitro cell culture or in vivo implantation, the released acids, if not 
removed timely, may change the local pH value dramatically and affect cell growth or 
induce inflammatory response (Cao and Shoichet, 1999). In this regard, the 
PHBV/PLGA composite microspheres, which showed an intermediate degradation rate 
between PHBV and PLGA of 55% loss of the initial mass by 110 days, would be more 
suitable since the moderate degradation can allow an effective exchange of acid by-
products to the surrounding environment. Since the degradation of PHBV was 
relatively slow, most of the mass loss here was likely to be resulted from the 
degradation of the PLGA component.  
The presence of metabolically active Hep3B cells were also observed not to have a 
significant effect on the degradation of the PHBV/ PLGA microspheres as observed by 
the mass loss (dotted line in Figure 5-2). Therefore, as both PLGA and PHBV are 
polyesters, the degradation of such polymers is attributed mainly to the hydrolysis of 
the ester bonds in the backbone. The enzymatic decomposition initiated by the cells, by 
comparison, would be negligible.  
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The degraded microspheres were observed under SEM to monitor the morphology 
changes due to degradation (Figure 5-3). After three months of incubation, PHBV 
microspheres still retained the original spherical shapes and did not show significant 
changes in surface and internal morphologies. This is consistent with the very slow 
mass loss observed in Figure 5-2. However, for PLGA microspheres, dramatic 
morphology changes were observed after one month of incubation. Although the 
PLGA microspheres still remained spherical, the structure looks quite loose, and the 
initial smooth surface turned into highly porous structures which probably resulted 
from the leaching out of the degradation products [Figure 5-3, panel C(3)]. PLGA 
microspheres degraded almost totally after two months and only aggregated debris was 
Figure 5-2. Degradation profiles of microspheres characterized by mass loss up to 
110 days for (   ) PHBV, (   ) PHBV/PLGA, and (   ) PLGA. Dotted line (   ) shows 
the degradation profile of PLGA/PHBV microsphere in the presence of Hep3B 
cells. Values represent means±SD, n=3. 
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left (figure not shown). The PHBV/PLGA composite microspheres also showed 
dramatic morphology changes after three months of incubation. The dense cores totally 
disappeared and a shell with a hollow core remained. In contrast, the shell was 
degraded heterogeneously and this resulted in a highly porous surface. This verified 
again that the core was occupied by PLGA while the shell was the blend of the two 
polymers (cf. Figure 5-1C). 
 
Figure 5-3. SEM images of PHBV (A) and PHBV/PLGA (B) microspheres after 90 
days of degradation, and PLGA (C) microspheres after 30 days of degradation, where 
panels labeled with 1, 2 and 3 respectively are the general morphology, cross section 
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BSA was used as a model protein for HGF because both BSA and HGF have 
similar molecular weights and BSA is a well-characterized protein with relatively low 
cost (Cao and Shoichet, 1999). Figure 5-4 shows the release profiles of BSA from the 
three types of microspheres. The release of BSA from pure PHBV microspheres 
reached around 88% after 6 days with a substantial initial burst (59.67%). The 
subsequent release was quite slow and reached around 94% by the end of 3 months. 
Since PHBV was not compatible with BSA (cf. section 5.2.2), most of the 
encapsulated proteins might be located near the surface, which could diffuse out very 
soon during the first week. In contrast, the pure PLGA microspheres provided a slow 
and linear release profile during the first two weeks. Given that the degradation of 
Figure 5-4. Cumulative release of BSA from (   ) PHBV, (   ) PHBV/PLGA, and (  ) 
PLGA microspheres. Values represent means±SD, n=3. 
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PLGA was insignificant during this period, the released BSA was most by diffusion 
from areas near the surface. It is interesting to note that the initial amount of BSA 
released is very small (cf. Table 5-1) which differs from commonly reported protein 
release profile with a burst more than 10% (Cao and Shoichet, 1999; Tan et al., 2005). 
This is probably due to the thorough washing process since the initial burst is believed 
to come from the proteins on the surface. The assumption was supported by surface 
atomic compositions of the microspheres (Table 5-2), the low nitrogen concentrations 
indicated small amount of proteins remained on the surface. The less porous surface of 
PLGA microspheres also reduced the diffusion rate of BSA during this initial period. 
The accelerated release after the initial diffusion was consistent with the accelerated 
mass degradation of the microspheres (cf. Figure 5-2). A linear release profile was 
achieved up to 60 days when microspheres were degraded totally with 100% release of 
BSA. The initial release (within the first week) of BSA from PHBV/PLGA 
microspheres is fast followed by a slow release plateau (from 7 days to 30 days), 
which differs from both pure PLGA and PHBV microspheres. The fast initial release 
could be attributed to the porous surface which allowed for the easy diffusion of 
proteins. It is worth noting that the accelerated release phase (from 30 to 70 days) is 
mainly due the degradation of PLGA, and was delayed as compared with PLGA 
microspheres (from 20 to 60 days). A possible explanation is that the hydrophobic 
PHBV shell can slow down the degradation as well as prevent the release.  
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Since the effects of HGF on Hep3B cells are concentration-dependent, the release 
profile of HGF was plotted in the form of actual concentrations of released proteins 
versus time for convenience (Figure 5-5). The different scales used here should be 
noted since the loadings of BSA and HGF were different, and thus the released 
concentrations were significantly different. As expected, the profile of HGF is similar 
to BSA released from PHBV/PLGA microspheres. This observation substantiates very 
well the hypothesis used in the present study that BSA is a reasonably good model 
protein for HGF. The detection of the growth factor by the ELISA kit also indicated 
Figure 5-5. Actual concentrations of released BSA (  ) and HGF (  ) from 
PLGA/PHBV microspheres. Values represent means±SD, n=3. Different scales were 
used to plot HGF and BSA for comparison purposes. 
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that the HGF was not denatured and thus reconfirmed the benefits of using BSA co-
encapsulated HGF as a protection agent in the double emulsion process.  
5.2.5 Bioactivity of the released proteins 
The bioactivity of HGF released from PHBV/PLGA microspheres was assessed by 
culturing Hep3B cells in the medium from the release study. Bioactive HGF is known 
to improve the proliferation of primary hepatocytes but inhibit the growth of various 
hepatoma cell lines, such as HepG2 and Hep3B. In previous chapters, Hep3B cell line 
has been used as a model for tissue engineering, the effects as determined in this 
section could similarly be used as a model for subsequent works with primary 
hepatocytes. The cell numbers after 24 hours incubation normalized from cellular 
DNA, were used as an indicator of bioactivity by comparing to a positive control (SF 
medium), and two negative controls (SF medium supplemented with 5 ng/mL and 50 
ng/mL HGF respectively). The medium from microspheres encapsulated with BSA 
alone served as a control for both the effects of released BSA on Hep3B cell 
proliferation and any potential cytotoxicity of the polymer degradation products. 
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As was shown in Figure 5-6, the growth inhibition effects of released HGF were 
significant as compared to the positive controls when cultured in the media from days 
1, 3 and 6 (P<0.05), and SF media supplemented with 50 ng/mL HGF showed similar 
inhibition effect. However, the media from days 10, 14 and 20 showed no inhibition 
effects which could be attributed to the significantly lower amount of HGF released. In 
order to verify this assumption, SF medium supplemented with 5 ng/mL HGF (being 
























































Figure 5-6. Hep3B cell proliferations measured by total-DNA assay after incubating 
the cells in the released HGF (   ) and BSA (   ) for 24 hrs. SF medium (   ) was used 
as the positive control, while SF medium containing 5 ng/mL (   ) and 50 ng/mL (  ) 
HGF were used as negative controls. Values represent means±SD, n=3. Statistical 
significance (* p<0.05) was determined by one-way ANOVA with Tukey’s HSD post 
hoc analysis as compared to the positive control, while (+p<0.05) was determined by 
t-test comparison between the two samples. 
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significant inhibition effect was found. The inhibition effects were observed again 
when culturing the cells in the media from days 30 and 40, which corresponds to 
higher HGF released from the microspheres (cf. Figure 5-5). A study by Shiota and 
colleagues indicated that the inhibition effects of HGF on Hepatoma cells (HepG2 and 
Hep3B) were dose-dependent up to 50 ng/mL and lower concentrations of HGF did no 
inhibit the growth of hepatoma cells (Shiota et al., 1992). Our results were consistent 
with these findings and indicated that the bioactivity of HGF released from 
PHBV/PLGA microspheres was preserved for at least 40 days. One interesting result 
was that the BSA released from BSA-alone encapsulated PHBV/PLGA microspheres 
showed positive effects on the proliferation of Hep3B cells as indicated by the black 
bars in Figure 5-6. Since the cells were cultured in SF medium, BSA was believed to 
serve as the nutrient for cell growth (Drumm et al., 2003). While the positive effects 
may have counteracted the inhibition effects of HGF for Hep3B cells (white bars in 
Figure 5-6) and which will be addressed, BSA will definitely function as a useful 
supplement when the scaffold is used to culture primary hepatocytes.  
5.2.5.2 Albumin secretion and P-450 activity 
The bioactivity of HGF was also assessed through measuring the human albumin 
secretion by Hep3B cells, which is one of the important hepatic functions (Figure 5-7). 
It is worth to note that, when the cells were cultured in HGF-containing media, the 
human albumin secretion per cell was lower than the cells cultured in the positive 
control, and the inhibition effects were dose-dependent which was consistent with 
what have been observed in Figure 5-6. The EROD assay showed a similar inhibition 
effect on the cytochrome P-450 activity of Hep3B cells by the released HGF (Figure 5-
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8). These results indicated that the HGF not only inhibited Hep3B cellular DNA 
synthesis for proliferation but also suppressed the differentiated function. The cells in 
this state are most likely related to the G0 phase of a cell cycle. The normal 
hepatocytes existing in the liver are mostly believed to be in the G0 or so called 
quiescent phase and they could rapidly respond to in vivo signals and re-enter the G1 
phase when the liver is damaged (Hansen and Albrecht, 1999). However, this kind of 
cell cycle is not regulated in cancer, and the cells keep dividing without staying in the 
quiescent state and will eventually develop into a tumor. Therefore, the release of HGF 
from the microsphere scaffold can also be used to suppress cancer cell growth.  
 
 
Figure 5-7. Albumin secretions by Hep3B cells after incubating the cells in the 
released HGF (    ) and BSA (    ) for 24 hrs. SF medium (    ) was used as the positive
control, while SF medium containing 5 ng/mL (    ) and 50 ng/mL (    ) HGF were 
used as negative controls. Values represent means±SD, n=3. Statistical significance (* 
p<0.05) was determined by one-way ANOVA with Tukey’s HSD post hoc analysis as 
compared to the positive control, while (+p<0.05) was determined by t-test 
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5.2.6 Culturing primary hepatocytes on PHBV/PLGA microsphere scaffold 
Primary hepatocytes were cultured on PHBV/PLGA microspheres for up to 10 
days to study the effects of the scaffold as well as the delivery of HGF on the growth 
of the cells.  
Figure 5-8. P-450 activity of Hep3B cells after incubating the cells in the released 
HGF (   ) and BSA (   ) for 24 hrs. SF medium (   ) was used as the positive control, 
while SF medium containing 5 ng/mL (   ) and 50 ng/mL (   ) HGF were used as 
negative controls. Values represent means±SD, n=3. Statistical significance (* 
p<0.05) was determined by one-way ANOVA with Tukey’s HSD post hoc analysis as 
compared to the positive control, while (+p<0.05) was determined by t-test 
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As was shown in Figure 5-9, the number of cells grown on the microsphere 
scaffolds remained significantly higher than that of the controls during the period of 
culture (*p<0.05). There was an increase in cell numbers from day 1 to day 3 followed 
by a slow decrease for the microsphere scaffold. However, the cell numbers decreased 
sharply from day 1 onwards when the cells were cultured on the controls. By the last 
day of culture, more than 50% of the original amount of cells remained on the 
microspheres while only 20-30% cells were found on the controls. It was reported that, 
when the primary hepatocytes were cultured in vitro without appropriate substrates and 
Figure 5-9. Proliferation of primary hepatocytes cultured on PHBV/PLGA
microspheres and controls as assessed by total-DNA assay. Cells were cultured on 
microspheres loaded with HGF (   ), blank microsphere (   ), while cell culture 
medium supplemented with 50 ng/mL of HGF (   ) or without HGF (    ) were 
used as controls. Values represent means ± SD, n=3. Statistical significance (* 
p<0.05) was determined by one-way ANOVA with Tukey’s HSD post hoc 
analysis as compared to the control, while (+ p<0.05) was determined by t-test 
comparison between the two samples.
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stimulus such as growth factors or co-culturing with other types of cells, the viability 
of the cell number would decrease quickly and the cells tend to de-differentiate and 
lose their normal functions (Bhandari et al., 2001). Our results are consistent with 
these findings and indicated that the three-dimensional environment provided by the 
microspheres can better maintain the viability of the primary hepatocytes. It is of worth 
to note that the number of hepatocytes cultured on the microspheres loaded with HGF 
was higher than that of the blank microspheres (+p<0.05), which was also much higher 
than the control with the media supplemented with 50 ng/mL HGF. As HGF is 
believed to improve the growth of the primary hepatocytes, we hypothesize that the 
localized and direct delivery to cells via the microspheres can protect the growth 
factors from proteolysis as well eliminating the dilution effect of solution delivery.  
5.2.6.2 Albumin secretion and P-450 activity of hepatocytes 
Two liver specific functions, cytochrome P-450 activity and albumin secretion 
were also measured quantitatively (Figure 5-10 and Figure 5-11). It can be seen that 
the differentiated functions were well preserved when the cells were grown on the 
microsphere scaffold as compared to the two-dimensional controls (*p<0.05). 
However, in comparing the microsphere loaded with HGF to the blank microspheres, 
no significant differences in the hepatic functions were observed (+p>0.1), which was 
also consistent with what was found when the cells were cultured on the two-
dimensional controls (tissue culture plates). It is thus hypothesized that the three-
dimensional structure of the scaffold plays an important role in preserving the 
phenotype of primary hepatocytes than the growth factor, while the HGF would more 
likely improve the cell proliferation.  
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Figure 5-10. Cytochrome P-450 activity of primary hepatocytes cultured on 
PLGA/PHBV microspheres and controls as assessed by total-DNA assay. Cells 
were cultured on microspheres loaded with HGF (    ), blank microsphere (    ), 
while cell culture medium supplemented with 50 ng/mL of HGF (   ) or without 
HGF (   ) were used as controls. Values represent means ± SD, n=3. Statistical 
significance (*p<0.05) was determined by one-way ANOVA with Tukey’s HSD 
post hoc analysis as compared to the control, while (+ p<0.05) was determined by t-
test comparison between the two samples.
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In this chapter, three types of polymer microspheres with distinct release profiles 
of protein were fabricated for potential application in liver tissue regeneration. Bovine 
serum albumin was proven to be a suitable model protein for hepatocyte growth factor 
(HGF) and functioned as a stabilizer to prevent the denaturation of HGF during the 
fabrication process. The composite microsphere (PHBV/PLGA), which was developed 
Figure 5-11. Albumin secretion by primary hepatocytes cultured on PLGA/PHBV 
microspheres and controls as assessed by total-DNA assay. Cells were cultured on 
microspheres loaded with HGF (   ), blank microsphere (   ), while cell culture 
medium supplemented with 50 ng/mL of HGF (    ) or without HGF (    ) were used 
as controls. Values represent means ± SD, n=3. Statistical significance (* p<0.05) 
was determined by one-way ANOVA with Tukey’s HSD post hoc analysis as 
compared to the control, while (+p<0.05) was determined by t-test comparison 
between the two samples. 
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with a core-shell structure, was shown to possess a moderate degradation rate, well 
preserved structure and better controlled delivery for HGF during the three months of 
incubation. The inhibition of Hep3B cells growth indicated that the HGF released from 
PHBV/PLGA microspheres maintained its bioactivity for at least for 40 days. 
Furthermore, the three-dimensional microsphere scaffold with the direct delivery of 
HGF to the cells grown on it was shown to be able to better maintain the viability and 
phenotype of the primary hepatocytes. This successful controlled release of HGF adds 
to previous works on using microspheres as scaffolds would push the progress towards 
a complete engineered liver tissue system. 
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Microsphere scaffold with bio-mimetic surface and ability to deliver growth 
factors to the cells in a controlled and localized manner shows great promise for the 
success of liver tissue regeneration. One of the challenges in successfully applying this 
scaffolding system is to efficiently provide nutrients and oxygen to the hepatocytes 
growing in the deeper sections of the scaffold to maintain their viability. Although 
diffusion is sufficient for thin tissue equivalents, it has not been sufficient to provide 
nutrients and oxygen to thick and complex tissue equivalents such as the liver (Frerich 
et al., 2001; Griffith et al., 2005; Levenberg et al., 2005). The lack of sufficient blood 
supply is believed to be the primary reason for the cell death that occurs in hepatocyte 
transplantation. Therefore, a vascularized scaffolding system which can provide 
nutrient and oxygen to maintain the viability of liver cells is a prerequisite for the 
success of engineering liver tissues.  
Although there are many factors affecting the formation of blood vessels in vitro, 
culturing endothelial cells on appropriate three-dimensional scaffolds is believed to be 
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the basis and premise for the success of vascularization (Nehls and Herrmann, 1996). 
In a study done by Griffith and his co-workers, human umbilical vein endothelial cells 
coated microcarrier beads were embedded in fibrin gels and the gel thickness varied to 
study the formation of capillary network in vitro (Griffith et al., 2005). Growth factors 
such as vascular endothelial cell growth factor (VEGF) and basic fibroblast growth 
factor (bFGF) and platelet-derived growth factors are also known to stimulate rapid 
formation of capillary vessels both in vivo and in vitro (Tabata and Ikada, 1998; Chen 
and Mooney, 2003; Riley et al., 2006). However, the effects of these factors by direct 
administration were found to be insignificant because of their poor stability resulting 
from proteolysis (Tabata and Ikada, 1998). Therefore, a localized delivery system 
which can maintain the concentration and bioactivity of growth factors for an extended 
period of time as well as provide the cells with the molecules directly is necessary for 
the success of vascularization. 
In this chapter, the application of microsphere scaffold is extended to in vitro 
vascularization. The strategy is to culture endothelial cells on gelatin microspheres 
(GMs), followed by incorporation into a fibrin gel. Angiogenic factors (bFGF) were 
also incorporated into the gelatin microsphere scaffold to further stimulate the 
vascularization process. The objectives were to examine the effects of cross-linking 
extent of GMs on the growth of endothelial cells, to investigate the incorporation of 
bFGF into the microspheres and its release profile, and to study the effects of growth 
factor on the cell activity and the development of capillary network in vitro. 
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6.1 Materials and Methods 
6.1.1 Materials 
Acidic gelatin with isoelectric point (IEP) of 5.0 was obtained from Japan 
(courtesy of Professor Tabata, Kyoto University). Olive oil was purchased from Wako 
Pure Chemicals (Osaka, Japan). Recombinant basic fibroblast growth factor (bFGF) 
was purchased from RayBiotech (Norcross, GA, USA). bFGF detection ELISA kit was 
purchased from Biolegend (San Diego, CA, USA). Ham’s F12 K medium, sodium 
bicarbonate, heparin, endothelial cell growth supplement (ECGS), fibrinogen and 
thrombin were purchased from Sigma-Aldrich (St. Louis, MO, USA). The information 
of the chemicals which were used in this chapter but not listed in this section can be 
found in section 3.1.1 in Chapter 3. All chemicals were used directly without further 
purification.  
6.1.2 Fabrication of gelatin microspheres 
The GMs were fabricated according to an established method (Tabata et al., 1999). 
Briefly, 4 g of gelatin was dissolved in 20 mL of water and heated up to 60ºC. 200 mL 
of olive oil was heated up to 40ºC. Gelatin was then added drop-wise into the olive oil, 
while stirring at 420 rpm with a mechanical stirrer (RW20, Ika Labortechnik, Staufen, 
Germany). The water-in-oil (w/o) emulsion was stirred for 10 minutes before being 
immersed into an ice bath to maintain the temperature at 10ºC and stirred for a further 
30 minutes. 60 mL of chilled acetone was then added and the mixture was stirred for 
another 1hour. The GMs were extracted from the olive oil by a series of centrifuging 
and washing with chilled acetone. Cross-linking was carried out by immersing the 
microspheres in 150 mL of three different concentrations of glutaraldehyde solution 
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(5mM, 10mM and 20 mM) and stirred at 420 rpm for 12 hours at 4ºC. Cross-linked 
microspheres were washed with deionized water and then suspended in glycine 
solution (50 mM) to block the un-reacted aldehyde groups for 2 hours in room 
temperature. The microspheres were then washed with acetone and dried with a freeze-
dryer (Alpha 1-4, Martin Christ, GmbH, Germany) for 24 hours to remove any 
remaining solvent.  
6.1.3 Characterization of the GMs 
The sizes of gelatin microspheres were estimated using a light microscope (Leica 
DMIL, GmbH, Germany). Dried and wet (saturated with deionized water for 3 hours) 
microspheres were observed under the microscope. The images were captured by a 
digital camera (QICAM Fast 1394, QIMAGING, Canada) and analyzed using built-in 
software to measure the diameter of individual microsphere. The swelling ratios were 






The external morphologies of GMs were characterized by a scanning electron 
microscope (SEM) (JSM-5600VL, JEOL, Tokyo, Japan). The microspheres were 
mounted onto brass stubs using double-sided adhesive tape and vacuum-coated with 
platinum using the Auto Fine Coater (JFC-1300, JEOL, Tokyo, Japan) for 40 s.   
The chemical structures (functional groups) of cross-linked GMs were examined 
with a Fourier transform infrared (FTIR) spectrometer (Excalibur Series, BioRad 
Laboratories, FTS, 135, USA). Briefly, 4 mg of the 10 mM microspheres was mixed 
with 96 mg of potassium bromide. The mixture was then grounded with a mortar and 
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pestle after which it was compressed into pellets under a pressure of 10,000 kg/inch-2 
for 10 min prior for IR examination. The IR frequency range of interest is 4000 cm-1 to 
400 cm-1. 
6.1.4 bFGF incorporation and in vitro release from GMs 
The bFGF was incorporated into GMs according to previously established method 
(Tabata and Ikada, 1998). Briefly, 5 μL of the bFGF solution (60 ng/μL, pH 7.4 ) was 
added to per mg of freeze-dried GMs cross-linked with GTA, followed by standing at 
4ºC overnight. The microspheres absorbed all of the bFGF solution during the swelling 
process since the volume was much less than the theoretical swelling saturation 
volume (Tabata and Ikada, 1998; Holland et al., 2005). Therefore, the incorporation 
efficiency of bFGF into GMs was considered as 100%.  
To determine the release profile, the bFGF-loaded microspheres were suspended in 
2 mL of PBS and incubated at 37°C. At set time points, the supernatant was collected 
and replaced with fresh PBS. The concentrations of bFGF in the supernatant were 
analyzed using an ELISA kit (Biolegend). 
6.1.5 Cell and cell culture 
Human umbilical vein endothelial cells (ATCC) were cultured in a serum-medium 
which was composed of Ham’s F12K  medium  supplemented with 10% v/v FBS, 1.5 
g/L sodium bicarbonate, 0.1 mg/mL heparin and 0.05 mg/mL ECGS. The cells were 
maintained in T-75 flasks in an incubator at 37ºC in the presence of 5% CO2 and 95% 
relative humidity. The medium was changed every three days. 
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6.1.5.1 Morphology of cell-microsphere constructs 
Light microscope: The morphologies of cells and cell-microspheres constructs 
were observed under optical microscope ((rf. 3.1.5 in Chapter 3).  
Scanning Electron Microscope (SEM): Clear and more detailed images of cell-
microsphere constructs were obtained by fixing the cells with 2.5 v/v% glutaraldehyde 
and observed under SEM (rf. 3.1.5 in Chapter 3).  
Confocal Laser Scanning Microscope (CLSM): The nucleus and actins of the 
HUVEC were stained and observed under CLSM (rf. 3.1.5 in Chapter 3). 
6.1.5.2 Cell metabolic activity by MTT assay 
The proliferations of the cells growth on GMs were quantified by using MTT 
assay. The detailed description of the assay can be found at 3.1.6 in Chapter 3. 
6.1.6 Culturing HUVEC on GMs cross-linked with different concentrations 
of GTA. 
GMs cross-linked with 5 mM, 10 mM and 20 mM GTA respectively, were 
sterilized with 70% ethanol followed by complete washing with sterilized PBS. The 
microspheres were then transferred into a 24-well plate (2 mg per well). Cells were 
subsequently seeded at 3 × 104 cells/well, or approximately 1.5 ×104 cells/mg of 
microsphere. Every half an hour, the plate was shaken gently for 2 minutes to improve 
the adhesion of the cells onto the microspheres (Wissemann and Jacobson, 1985). A 
blank well coated with gelatin (0.5%) was used as the control. After three hours, the 
plates were put into the incubator.  
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6.1.7 Culturing HUVEC on GMs incorporated with bFGF 
Six hundred ng of bFGF were incorporated into 2 mg of sterilized GMs (rf. 6.1.4). 
HUVEC were then seeded onto the microspheres as described above. Microspheres 
without incorporating growth factors and blank well coated with gelatin were used as 
controls. To compare the effects of free administration of the growth factors to the 
cells, cell culture medium supplemented with 60 ng/mL of bFGF was used a third 
control to culture the cells grown on gelatin-coated wells. GMs cross-linked with 10 
mM GTA were used in this assay.  
6.1.8 An in vitro model of vascularization 
In each well of a 24-well plate, 3 × 104 HUVEC cells were grown on 0.5 mg GMs 
confluence. The cells coated GMs were then suspended in 200 µL of fibrinogen 
solution (2 mg/mL in PBS, pH=7.6, filter-sterilized). 10 µL of thrombin solution (25 
U/mL, in PBS, pH=7.6, filter-sterilized) was added in before the plate was incubated 
for 30 min at 37 ºC. After the fibrin gel was formed, 0.8 mL of cell culture medium 
was added to each well. The migration of cells into the fibrin matrix was observed 
under optical microscope.  
6.1.9 Statistical Analysis  
All data were presented as mean ± standard deviation and were analyzed by a one-
way ANOVA followed by Tukey’s HSD post hoc analysis, where the “*” (p<0.05) 
indicate significant differences of the samples to the control (Tissue culture plate 
coated with gelatin). Student’s t-test were also carried out for statistical comparisons 
between pairs of samples, where the “†” indicate significant difference (p<0.05).  
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6.2 Results and Discussion 
One of the major obstacles in engineering thick tissues such as the liver is the lack 
of sufficient supply of nutrients and oxygen to the cells. The potential solution is to 
encourage the development of a vascular network within the three-dimensional tissue 
engineering matrices before it can be used for implantation. In this work, gelatin 
microspheres were used to guide human umbilical vein endothelial cells adhesion and 
proliferation as a potential system for vascularization. The choice of gelatin as the 
scaffold material is justified by the fact that gelatin is one of the most commonly used 
natural polymer for biomedical applications (Goodstone et al., 2004; Layman et al., 
2007). More important, gelatin is a denatured form of collagen with all of its cell-
adhesive properties and also with different isoelectric points obtained by acid or 
alkaline processing. Therefore, the positively or negatively charged gelatin can interact 
with growth factor molecules with opposite charges to form ionic complexation for a 
sustained release system (Tabata and Ikada, 1998; Tabata et al., 1999; Holland et al., 
2005). 
6.2.1 Fabrication and characterization of the GMs 
GMs were fabricated using a water-in-oil process, and further cross-linked with 
glutaraldehyde of different concentrations, namely 5 mM, 10 mM and 20 mM 
respectively. Cross-linking was achieved by the reactions between aldehyde groups of 
GTA and the ε-amino groups of the lysine residues in gelatin to form aldimine 
linkages which induced a color change. 
As shown in Figure 6-1, all of the GMs have spherical shapes with uniform sizes, 
and the surfaces were very smooth (see the Insert in Figure 6-1C). It can be seen from 
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the light micrographs [Figure 6-1(E) and 6-1 (F)] that the translucent microspheres 
tend to swell when immersed in water and turn transparent. Although the overall 
morphologies and sizes of the dried GMs were not significantly affected by the 
concentrations of the cross-linker, the microspheres cross-linked with higher 
concentrations of GTA showed smaller swelling ratios, which indicated a relatively 
more rigid structure. The degradation of GMs can also been tuned by changing the 
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 The mean diameters of dry microspheres were 60.2, 59.2, 60.6, and 61.3 µm 
respectively with small standard deviations (SD), and the wet diameters were 108.5, 
100.1, 98.2 and 96.7µm (Table 6-1). Swelling ratios based on volume indicate that 
with higher cross-linking extent, the GMs tend to absorb less water, and therefore had 
(A) (B)
(D)
Figure 6-1. SEM images of GMs. (A) Non-cross-linked, and cross-linked with GTA 
at the concentrations of (B) 5 mM, (C) 10 mM and (D) 20 mM. Light micrographs 
of (E) Dry and (F) Wet gelatin microspheres cross-linked with 10 mM GTA. 
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a smaller swelling ratio. The colors of the microspheres also changed from pale to deep 











Non-crosslink 60.2 ±  6.3 108.5 ±  8.3 5.85 
5 mM 59.5 ±  5.6 100.1 ± 5.2 4.76 
10 mM 60.6 ±  5.1 98.2 ± 6.5 4.26 
20 mM 61.3 ±  8.3 96.7 ± 3.6 3.93 
 
 
The FTIR spectrum (Figure 6-2) showed two common absorption bands for 
proteins, the C=O stretching at 1650 cm-1 and the NH stretching at 3300 cm-1. The 
characteristic absorptions of the backbone of gelatin molecules occurring at 1540 cm-1 
and 1650 cm-1 were also observed. Pale GMs changed color to deep orange due to the 
establishment of aldimine linkages (CH=N), between the free amino groups of protein 
and glutaraldehyde. The aldimine absorption peak at 1450 cm-1 which represents cross-
linked gelatin was present but weak compared with other’s work. This could be due to 
the significantly lower concentrations of glutaraldehyde used in this work.  
 
 
Table 6-1.   Size and swelling ratio of gelatin microspheres 
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6.2.2 Culturing HUVEC on GMs cross-linked with different concentrations 
of GTA 
6.2.2.1 Light microscope images 
Light micrographs of HUVEC cultured on GMs cross-linked with 10 mM GTA are 
shown in Figure 6-3. It can be seen that the cells with round shapes were mainly 
attached to the microspheres with less spreading on the initial adhesion stage [Figure 
6-3 (A)], which indicated very good biocompatibility of the GMs for the HUVEC cells. 
After one day, the cells spread over the surface of single microspheres and began to 
bridge adjacent microspheres together [Figure 6-3 (B)]. By one week of culture, cells 
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were seen to become confluent on the scaffolds and stretched to fill the gaps between 
the microspheres to form large cell-microsphere clusters [Figure 6-3 (C)]. Compared to 
two-dimensional cultures on the blank wells, the cells showed more elongated shapes 
and strong interactions with adjacent cells and substrates. The interactions would not 
only improve the proliferation of the cells but could also stimulate the differentiation 
of the cells to develop into blood vessels. The cell-microspheres clusters formed after 
one week of culture could be ideal since during early angiogenisis in vivo, angiogenic 
cells form cluster processes which then coalesce to form blood vessels (Buschmann 
and Schaper, 2000). After the degradation of the GMs, the remaining blank spaces will 
enable the cells to develop into vascular networks.  
In order to get clearer view on how the cell grew on the scaffold, individual 
microsphere was isolated after the initial adhesion stage, and the results are shown in 
the right column of Figure 6-3 [(D), (E) and (F)]. The cells grown on GMs cross-
linked with 5 and 20 mM GTA showed a similar profile (Data not show). 
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Figure 6-3. Optical micrographs of the morphologies of HUVEC cells grew on GMs
after (A, D) Three hours (initial adhesion), (B, E) 1 days, and (C, F) 7 days of culture. 
The right column indicated the cells grew on individual microsphere, while the left 
column indicated the cell-microsphere clusters. The microspheres were cross-linked 
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6.2.2.2 SEM and CLSM images 
Clearer and more detailed images of cell-scaffold morphologies can be obtained by 
using SEM and CLSM. Images in Figure 6-4 were taken after one week of culture. The 
SEM images showed that the surface of microspheres was covered by cells which 
deposited an abundant amount of extracellular matrix proteins, and there existed strong 
cell-cell interaction and cell-substratum interaction between cells and the microspheres. 
In the confocal images, the cell nucleus were dye with DAPI (blue color), and the 
actins were dye with phalloidin-FITC (green color). It can be seen that the cells evenly 
spread and covered the surfaces of the microspheres. The extensively elongated cells 
with stretched actins bridged the adjacent microspheres together and indicated very 
strong cell-microsphere interactions. 
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6.2.2.3 Cell proliferation measured by MTT assay 
The proliferation rates of HUVEC cultured on the GMs as well as on the control 
were quantitatively evaluated by MTT assay during the 10 days of culture as shown in 
Figure 6-5. It can be seen that the cell proliferation rates on the three types of 
microspheres were much higher than that of the control (*p<0.05). From day 3 to day 
6, there was a sharp increase in cell proliferation and confluence was reached by day 
Figure 6-4. SEM (A, B) and CLSM (C, D) images of HUVEC grew on GMs after 
one week. Cell actin was dyed with Phalloidin-FITC, and the nucleus was dyed 
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10.  The cells grown on GMs with higher cross-linker concentration also showed 
higher proliferation rate than that of the microspheres cross-linked with lower 





































It was believed that the rigidity of the substrate has an affect on the gene 
expression of cytoskeletal proteins and therefore can regulate the morphology and 
proliferation of the cells (Mooney et al., 1992). Our results were consistent with this 
finding as higher proliferation rates were observed with cells grown on GMs with 
Figure 6-5. Proliferation of HUVEC cells cultured on gelatin microspheres cross-
linked with different concentrations of GTA as assessed by MTT assay. 5 mM 
(    ), 10 mM (    ), 20 mM (    ). Blank well was used as the control (    ). Values 
represent means±SD, n=3. Statistical significance (*p<0.05) was determined by 
one-way ANOVA with Tukey’s HSD post hoc analysis as compared to the control, 
while (+p<0.05) was determined by t-test comparison between the two samples. 
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higher cross-linking extent and therefore high rigidity (Figure 6-5). Figure 6-5 also 
dictated higher cell proliferation on GMs as compared to blank wells of a tissue culture 
plate. One reason for this is that as compared to two-dimensional tissue culture plates, 
microspheres have a larger surface area providing for larger number of cells to grow. 
More importantly, it is believed that the shape of the scaffold affects cell adhesion, 
proliferation and function greatly (Malda et al., 2003; Barrias et al., 2005). As shown 
in Figure 6-3 and Figure 6-4, microspheres scaffold improved cell-cell interaction and 
cell-substrate interactions which may stimulate cell proliferation. The cells would also 
be more active in aggregate forms.  
6.2.3 bFGF incorporation and in vitro release from GMs 
As hydrogel beads, the GMs used in this work have high swelling ratios (Table 6-
1). 5 µL of bFGF aqueous solution is much less than the theoretical volume for 1 mg 
GMs to absorb. The incorporation efficiencies therefore can be assumed to be 100%. 
Shown in Figure 6-6 are the in vitro release profiles of bFGF from GMs cross-linked 
with 5 mM, 10 mM and 20 mM GTA respectively. Irrespective of the microsphere 
type, there was an initial burst release of bFGF (24 hour) at a certain amount followed 
by small amount of protein release for up to two weeks. However, for the microspheres 
cross-linked with different concentrations of GTA, namely, 5 mM, 10 mM and 20 mM 
GTA, the initial bursts were also significantly different at 23.9%, 13.3% and 8.2% 
respectively. Up to two weeks of incubation, the accumulated releases were 41.4%, 
26.1% and 12.9% respectively, and a plateau was observed thereafter. 
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The results indicated that highly cross-linked microspheres released less 
cumulative bFGF as well as having a lower initial burst compared to mildly cross-
linked microspheres which could be attributed to the cross-link networks. The 
incorporation of growth factors into GMs are based on ionic complexation between 
positively charged bFGF (IEP of 9) and negatively charged acidic gelatin molecules 
(IEP of 5.0). Since cross-linking is achieved by the reaction between glutaraldehyde 
and the ε–amino group of the lysine residue of the protein chains, this process could 
change the charges of the GMs and therefore change the complexation process. 
 
Figure 6-6. Cumulative release of bFGF from gelatin microspheres cross-linked with 
different concentrations of GTA. 5 mM (   ), 10 mM (   ), 20 mM (   ). Values 
represent means±SD, n=3. 
Chapter 6 
 
137                        












6.2.4 Culturing HUVEC on GMs incorporated with bFGF 
The bioactivity of bFGF released from GMs cross-linked with 10 mM GTA was 
assessed by culturing HUVEC on the microspheres and controls. Bioactive bFGF is 
known to stimulate in vivo angiogenesis and to improve the proliferation of various 
types of cells, such as endothelial cells and fibroblasts. As shown in Figure 6-7, the 
proliferation rate of HUVEC culturing on GMs loaded with bFGF was improved 
significantly as compared to the control (blank well) by about two times (*p<0.05) 
Figure 6-7. Proliferation of HUVEC cells cultured on gelatin microspheres and 
controls as assessed by MTT assay. Microspheres loaded with bFGF (   ), blank 
microsphere (   ). Cell culture medium supplement with 60 ng/mL of bFGF (   ) or 
without bFGF (   ) were used as controls. Values represent means±SD, n=3. 
Statistical significance (*p<0.05) was determined by one-way ANOVA with 
Tukey’s HSD post hoc analysis as compared to the control, while (+p<0.05) was 
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during the 10 days of culture which indicated that the bioactivity of bFGF was well 
maintained during the incorporation and release process by GMs.  
It is also of worth to note that the cells showed improved activity in cultures with 
bFGF released directly from the GMs as compared to the media supplemented with 60 
ng/mL bFGF. This could be due to the poor stability of the free growth factors resulted 
from proteolysis. It is also hypothesized here that the localized and controlled delivery 
directly to cells grown on the GMs can protect the growth factors from proteolysis as 
well provide the cells with the molecules without the dilution effect in solution. By 
comparing microspheres loaded with bFGF to microspheres without bFGF, there was 
also significant improvement of the proliferation from day 3 onwards (†p<0.05).  
6.2.5 Gelatin microsphere-based in vitro vascularization model 
HUVECs coated GMs were embedded into a fibrin gel to stimulate the formation 
of capillary network in vitro. As was shown in Figure 6-8, after one day of culture, the 
cells which were grew on blank GMs just migrated into the gel, they did not form any 
capillary networks. On the contrary, capillary networks were developed when the cells 
grew on GMs incorporated with bFGF [Figure 6-8 (C)] and the bFGF was added as a 
supplement of the cell culture medium [Figure 6-8 (B)], which indicated that bFGF 
played an essential role in stimulating the remodeling of endothelial cells in the fibrin 
gel to develop into blood vessels. However, it was also found that the freely 
administered bFGF only gave strong angiogenic response initially, but failed in long-
term stabilization. After five days of culture, the bFGF added as a supplement to the 
cell culture medium did not further stimulate the development of the capillary network 
in the fibrin gel [Figure 6-8 (E)], while the cells growing on GMs incorporated with 
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bFGF continued to remodel, developing an extensive capillary network among 
neighboring beads [Figure 6-8 (F)]. As discussed in previous section (6.2.4), the 
localized and controlled delivery of the growth factors directly to cells via the substrate 
might be more efficient in stimulating the in vitro vascularization since the bioactivity 
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Figure 6-8. In vitro formation of capillary network using HUVEC-coated GMs
embedded into a fibrin gel. (A, D) HUVEC grown on blank GMs, (B, E) HUVEC 
grown on blank GMs with bFGF as supplement of the cell culture medium and (C, F) 
HUVEC grown on GMs incorporated with bFGF. The left column indicated the cells 
grew in the gel for 1 day, while the right column indicated the cell grew in the gel for 5 
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6.3 Conclusion 
In this study, gelatin microspheres fabricated using a water-in-oil emulsion 
technique were studied as a scaffold for culturing human umbilical vein endothelial 
cells for the application of in vitro vascularization. As compared to cells cultured on 
tissue culture plates, cells grown on microsphere scaffold showed much higher 
proliferation rates and elongated morphologies. The cells also showed higher 
proliferation rate when cultured on gelatin microspheres cross-linked with higher 
concentrations than lower concentrations of glutaraldehyde. Basic fibroblast growth 
factor was subsequently incorporated into the gelatin microspheres based on ionic 
complexation. The improved cell proliferation with controlled release of bFGF, 
compared to blank microspheres indicated that the bioactivity of bFGF was well 
maintained during the incorporation and release. In the presence of bFGF, capillary 
networks were developed when HUVECs coated gelatin microspheres were embedded 
in a fibrin gel, and the controlled and localized delivery of bFGF to the cells further 
stabilized the network in vitro. 
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This study investigated the viability of using a novel polymer microsphere as 
scaffolds for liver tissue regeneration. First, the sizes of the microsphere were 
optimized to guide the growth of liver cells. The viability of the scaffold was further 
improved through surface conjugation with extracellular matrix proteins and 
encapsulation of growth factors.  
7.1 Conclusions 
Polymeric microspheres fabricated from poly(3-hydroxybutyrate-co-3-
hydroxyvalerate) (PHBV, 8% PHV) using emulsion solvent evaporation method, were 
investigated as novel scaffolds for liver tissue regeneration. Compared with cells 
cultured on two-dimensional controls, cells grown on microsphere scaffold showed 
higher proliferation as well as improved hepatic functions. This could be attributed to 
the large surface area provided by the microspheres, which allowed for larger cell 
populations. More importantly, it is believed that the spherical shape of the scaffold 
affects cell adhesion, proliferation and function greatly. Smaller microspheres 
improved cell-cell interaction and cell-substrate interaction which can stimulate cell 
proliferation and function. It was found that PHBV microspheres with the size range 
between 100-300µm were the most suitable to support growth of the liver cells. The 
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microspheres were assembled by the cells into various shapes after two weeks of 
culture, which would be desirable for the defects with irregular structures or organs 
with complex architecture. Although multilayers of cells was formed among the cell-
scaffold constructs, the viability of the cells was well preserved as confirmed by 
live/dead assay. 
We have also demonstrated that the biocompatibility of the PHBV microsphere 
scaffolds can be improved through surface conjugation with extracellular matrix (ECM) 
proteins, namely collagen, laminin and fibronectin. Successful conjugations of protein 
molecules were verified by the presence of nitrogen peaks in X-ray photoelectron 
spectroscopy (XPS) and fluorescence microscope. The improved proliferation of cells 
cultured on the combination of three protein-conjugated microspheres suggested that 
the proliferation activity of Hep3B did not just depend on single protein, but rather, 
involved complex interactions with all of the ECM components. Therefore, 
combinations of ECM components is important not just in improving the 
biocompatibility of tissue engineering scaffolds, but also in enhancing cellular function. 
Furthermore, hepatocytes with round morphology were found to possess better hepatic 
functions while having lower proliferation. Conversely, high proliferation would tend 
to lower cell function. Thus, in the design of a tissue engineering system, a scaffold 
showing different surface properties at different cell development stages might be 
necessary.  
One advantage of using microspheres as scaffold is that growth factors can be 
encapsulated into the scaffold directly. Three types of polymer microspheres with 
distinct release profiles of protein were fabricated. The composite microspheres 
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(PHBV/PLGA), which were developed with a core-shell structure, were shown to 
possess a moderate degradation rate, well preserved structure and better controlled 
delivery for hepatocyte growth factor (HGF) during three months of incubation. The 
inhibition of Hep3B cells growth indicated that the HGF released from PHBV/PLGA 
microspheres maintained its bioactivity for at least for 40 days. Furthermore, the three-
dimensional microsphere scaffold, with direct delivery of HGF to the cells grown on it, 
was shown to better maintain the viability and phenotype of the primary hepatocytes. 
Bovine serum albumin was also proven to be a suitable model protein for HGF and 
functioned as stabilizer to prevent the denaturation of HGF during the fabrication 
process. 
Vascularization of the scaffold system to provide the cells with nutrients and 
oxygen efficiently is a prerequisite for the success in engineering large tissues such as 
the liver. Gelatin microspheres based three-dimensional vascularization in vitro was 
studied. As compared to cells cultured on tissue culture plates, human umbilical vein 
endothelial cells (HUVECs) grown on gelatin microspheres showed much higher 
proliferation rates and elongated morphologies. The cells also showed higher 
proliferation rate when cultured on gelatin microspheres cross-linked with higher 
concentrations than lower concentrations of glutaraldehyde. Basic fibroblast growth 
factor (bFGF) was subsequently incorporated into the gelatin microspheres based on 
ionic complexation. The improved cell proliferation with controlled release of bFGF, 
compared to blank microspheres, indicated that the bioactivity of bFGF was well 
maintained during the incorporation and release process. In the presence of bFGF, 
capillary networks were developed when HUVECs coated gelatin microspheres were 
Chapter 7 
 
145                        
   
 
embedded in a fibrin gel, and the controlled and localized delivery of bFGF to the cells 
further stabilized the network in vitro. 
In summary, we have developed a novel and versatile tissue engineering system 
using polymeric microspheres as the scaffold. This versatility includes not just the ease 
of scaffold assembly into various shapes suitable for different tissue applications, but 
also offers easy and controllable surface modification and growth factor encapsulation 
properties as well as in vitro vascularization. This system has great potential for 
regeneration of liver tissue or any other large tissue to reduce the cost of implantation 
and solve the shortage of organ donors.  
7.2 Recommendations for Future Works 
7.2.1 In vivo animal test 
The present work focuses on demonstrating the viability of using microspheres as 
tissue engineering scaffold. In vitro cell culture is believed to be adequate to achieve 
this purpose. However, in vivo animal tests can further verify this viability and give us 
better understanding of the interactions between the engineered liver tissue and the 
host. This is also the necessary step before it can be applied for human liver tissue 
regeneration. Therefore, implantation of the engineered liver tissue with microsphere 
scaffold into animal models (rats or mice) is suggested for future work. For convenient 
surgical operation, the cell-microsphere constructs could be embedded into 
biocompatible gel before implantation. Sodium alginate which is polysaccharide, could 
be a good candidate due to its hydrophilicity and biocompatibility. Soluble sodium 
alginate is water soluble, and it can be cross-linked with divalent cations such as 
calcium, to form an insoluble alginate gel (Marijinissen et al., 2002; Wang et al., 2003).  
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7.2.2 Co-culturing hepatocytes with nonparenchymal cells 
A major challenge in constructing an engineered functional liver tissue is the short-
term survival and rapid de-differentiation of hepatocytes in in vitro culture. Cell-cell 
interactions (homotypic and heterotypic) have been proved to play an important role in 
modulating and preserving the phenotype of primary hepatocyte. Many researches 
have shown that co-culturing hepatocytes with nonparenchymal cells such as fibroblast 
can preserve hepatocyte morphology and the synthetic, metabolic and detoxification 
functions of the liver (Bhatia et al., 1997; Bhandari et al., 2001). Similar conclusions 
have also been obtained by co-culturing hepatocytes with liver-derived cells such as 
Ito cells and epithelial cells (Mesnil et al., 1987; Loreal et al., 1993;). Therefore, co-
culturing primary hepatocyte with fibroblast and endothelial cells is suggested for 
future work. The three types of cells could be firstly cultured on different sets of 
microspheres. After the cells grow to confluency, different cells attached microspheres 
could be then mixed in different ratios to form a co-culture system. The heterotypic 
interactions between different cell types could be studied by changing the ratios of the 
microspheres.  
7.2.3 Dual growth factor delivery system 
 PHBV/PLGA composite microsphere with core-shell structure can encapsulate 
different growth factors in its core and shell separately. In this case, the release of 
different growth factors could be controlled in a time and spatial sequence which could 
be useful in simulating the in vivo environment of human body. For example, in skin 
wound healing, platelet-derived growth factor is applied as the early mediator of 
inflammatory process, and then basic fibroblast growth factor is applied as an 
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angiogenic factor to accelerate healing and improve the healing quality. Due to time 
constrain, this is not covered in this thesis. Future work could involve encapsulating 
two growth factors or even multiple growth factors and releasing them in a desired 
sequence. This would be very useful not only for tissue regeneration but also for 
growth factor therapies.  
7.2.4 Other tissue regeneration using microsphere scaffold 
Small microspheres can be self-assembled into various shapes which could be 
fitted into irregular shaped implantation sites without arousing inflammatory response. 
For regeneration of large organ such as heart and kidney, it is not always feasible to 
fabricate a big polymer scaffold with the same shape as the organs due to limitations of 
experimental conditions. The self-assembly ability of microspheres may address this 
difficulty since small scale tissue units are formed initially in vitro. Large organ might 
eventually be regenerated by implanting these tissue units. Therefore, besides 
regeneration of liver tissue, regeneration of other tissue could be attempted by using 
the microsphere scaffolding system discussed in this thesis. 
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